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EPIDEMIOLOGICAL INVESTIGATIONS OF BIGHORN SHEEP RESPIRATORY 
DISEASE AND IMPLICATIONS FOR MANAGEMENT 
BRANDI FELTS 
2020 
Infectious respiratory disease has long been identified as the cause of bighorn 
sheep (Ovis canadensis) historical declines and extirpations, and Mycoplasma 
ovipneumoniae (Movi) is the primary pathogen inducing disease and mortality.  
Population-level effects of pneumonia events range from mild to extirpation.  Variable 
individual response to pathogen exposure emerges from dynamic interactions between 
competing evolutionary processes within the host and pathogen.  Understanding impacts 
of this evolutionary warfare is essential to assessing long-term impacts of pathogen 
invasion and developing appropriate countermeasures to protect population health.  Free-
ranging populations are faced with spillover infections from domestic sheep and goats as 
well as previously infected conspecifics.  The introduction of a novel Movi strain from a 
spillover event can result in high all-age morbidity and subsequent mortality.  We studied 
the effects of indirect and direct infection of captive bighorn sheep with Movi, a 
genetically diverse pathogen.  We also used known Movi-carriage histories to classify 
ewes into 1 of 3 Movi carrier classes.  We tested the hypothesis that respiratory disease 
persistence within bighorn sheep populations is driven by chronically Movi infected 
ewes, and the prediction that lambs born in pens with at least one chronic carrier ewe 
(treatment) would experience Movi-induced pneumonia mortality whereas lambs born in 
pens without a chronic carrier ewe (control) would not develop fatal pneumonia.  When 
xii 
all mortality causes were pooled across all years of our study, the percentage of lambs 
that did not survive was more than twice as high when lambs were in born in pens 
containing at least one Movi chronic shedder ewe (treatment), compared to when only 
Movi negative and/or intermittent ewes were present in the pen (control; 92% (n = 33 of 
36) and 38% (n = 5 of 13).  The mean probability of pneumonia-induced mortality for 
commingled lambs was above 0.75 by 15 days of age and generally remained above that 
level for the duration of the study.  Our model also estimated this probability to be 
elevated (≥ 0.90) as early as 16 days of age until 45 days of age, and a secondary peak for 
older, nearly weaned, lambs (105–114 days of age).  While conducting a study for Movi 
detection probability in serial samples, we document unilateral Movi colonization and 
direct managers on field sampling techniques for reliable disease surveillance of bighorn 
sheep populations.  Our results suggest that active disease control efforts must account 
for multiple Movi strains to prevent spillover epidemics.  Our results also underscore that 






CHAPTER 1: INDIVIDUAL BIGHORN SHEEP RESPONSE TO INFECTION BY A 
GENETICALLY DIVERSE PATHOGEN: IMPLICATIONS FOR FREE RANGING 
POPULATIONS 
This chapter is being prepared for publication and was coauthored by Daniel P. Walsh, 
Thomas E. Besser, E. Frances Cassirer, and Jonathan A. Jenks. 
2 
ABSTRACT  
Variable individual response to pathogen exposure emerges from dynamic 
interactions between competing evolutionary processes within the host and pathogen.  
The host’s adaptive immune system recognizes pathogens to which it has previous 
exposure and mounts a defensive immune response.  Pathogens have evolved strategies 
to overcome adaptive immune defenses including maintaining high genetic diversity 
through rapid evolution.  Alteration of surface exposed antigenic epitopes results in 
diverse strain types unrecognizable by the immunological memory of the adaptive 
immune system.  Understanding impacts of this evolutionary warfare is essential to 
assessing long-term impacts of pathogen invasion and developing appropriate 
countermeasures to protect population health.  During an epizootic of respiratory disease, 
we had the opportunity to examine impacts of pathogen diversity on individual hosts 
using captive bighorn sheep (Ovis canadensis) infected by genetically diverse strains of 
Mycoplasma ovipneumoniae (Movi).  We monitored clinical signs of 37 bighorns, housed 
in nine pens, with previous exposure to known strains of Movi, during an epizootic 
dominated by a specific Movi strain.  We found higher levels of antibody to Movi prior 
to the epizootic were associated with lower likelihood of exhibiting clinical signs of 
pneumonia (median of posterior distribution of the antibody levels prior to the outbreak 
(Movi %II) = -10.14; 95% CI = -21.79 – -1.40).  However, in symptomatic individuals, 
higher antibody levels were associated with more severe disease, with increased 
probability (median = 3.21; 95% CI = 0.57 – 7.39) and speed of pneumonia-induced 
mortality (median = 1.10; 95% CI = 0.18 – 2.23), and reduced likelihood of returning to 
an asymptomatic state (median = -2.31; 95% CI = -5.52 – -0.05).  Bighorn sheep that had 
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previous exposure to a strain other than the dominant epizootic strain were more likely to 
recover (median = 5.29 – 6.44; 95% CI = 0.42 – 14.51) suggesting factors other than 
adaptive immunity also were important for recovery to an asymptomatic state.  Our 
results suggest that Movi-strain variability was sufficient to overcome adaptive bighorn 
immunological defenses, but cofactors such as pathogen virulence, dose response, and 
contact patterns may be important drivers of heterogeneity in response to pathogen 
invasion.  These finding also suggest that active disease control efforts must account for 
multiple strains. 
 
KEY WORDS: bighorn sheep, disease state, hazard, immune response, mortality, 
Mycoplasma ovipneumoniae, strain, transmission 
 
INTRODUCTION 
Pathogens and their hosts are involved in on-going evolutionary warfare.  Many 
hosts have evolved immunological defenses including the adaptive immune system, 
which the host uses to recognize pathogens to which it was previously exposed and 
thereby mounts a rapid immune response to combat infection. Successful pathogens have 
evolved various complex and efficient methods to evade, circumvent, or overcome innate 
and adaptive host immune defenses, resulting in increased disease severity or duration of 
infection of the host (Finlay and McGadden 2006).  One subtle but highly successful 
mechanism, employed by pathogens to evade adaptive immunity, is rapid evolution 
resulting in alteration of surface exposed antigenic epitopes, which leads to multiple and 
genetically diverse strain types (Bloom 1979).  Pathogen genetic diversity has 
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implications for individual host response to infection and ultimately determines the 
pathogen’s virulence, transmissibility, and severity of epidemiological outbreaks 
(Coscolla and Gagneux 2010, Chae and Shin 2018).  Extensive literature describing 
antigenic variation within Mycoplasma (class Mollicutes), the smallest and simplest self-
replicating organisms, have been communicated (Christiansen et al. 1997, Citti et al. 
2010, Betlach et al. 2019, Qin et al. 2019).  Therefore, this variation is of fundamental 
importance in determining the underlying dynamics of host–pathogen interactions.  We 
investigated these host-pathogen interactions by examining the impacts of pathogen 
genetic diversity on individual bighorn sheep. 
Mycoplasma ovipneumoniae (Movi) is a primary etiologic agent of pneumonia in 
bighorn sheep (Besser et al. 2012b, Besser et al. 2013, Cassirer et al. 2018).  Movi is a 
common pathogen of domestic sheep and goats that exhibits a high degree of genetic 
(strain) and phenotypic heterogeneity (Ionas et al. 1991a, b, Parham et al. 2006, 
Maksimović et al. 2017, Kamath et al. 2020). Infection of bighorn sheep by Movi, 
typically occurs after contact with a live animal reservoir, and is often followed by 
epizootic transmission with high pneumonia morbidity affecting all age classes with 
variable mortality (Besser et al. 2014, Cassirer et al. 2018).  Surviving bighorn sheep 
exhibit variable responses to Movi infection.  Most sheep clear Movi infections (with 
immunity restricted to that strain), although some become chronic carriers which 
persistently shed the pathogen in the upper respiratory tract (Cassirer et al. 2017, 
Plowright et al. 2017).   
Individual host response and resulting dynamics of disease, including severity of 
the epizootic, within and among bighorn sheep populations is shaped by heterogeneities 
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in Movi strain-specific virulence, Movi infection dosages, and prior Movi exposure 
histories.  The resulting long-term population-level impacts of exposure to Movi varies 
from full recovery to functional or local extinction (Foreyt and Jessup 1982, Singer et al. 
2000, Sells et al. 2015).   
Describing factors such as exposure history or adaptive immune responses 
associated with individual and population variation in disease severity and persistence 
addresses an important knowledge gap for mitigating impacts of pneumonia and restoring 
bighorn sheep populations.  To fill this gap, we used information collected prior to and 
during a bighorn sheep pneumonia epizootic within a captive herd to investigate the 
heterogeneity in individual disease response in relation to pathogen strain type and 
exposure history.  We then modeled the effects of pathogen genetic diversity on host 
population dynamics based on the observed individual host responses to understand how 
these factors may drive epizootics in free-ranging bighorn sheep populations. 
METHODS 
Study Area 
We used information from South Dakota State University (SDSU) Captive 
Wildlife Research Facility in Brookings, South Dakota (44°20´ N, 96°47´ W) collected 
on 34 bighorn sheep transported from free-ranging populations in Washington (n = 13, 2 
populations), Oregon (n = 5), Idaho (n = 2), South Dakota (n = 3) and Nevada (n = 11), 
and animals >1 year of age (n = 3) born to the Washington-origin sheep in captivity at 
SDSU.  Temperature at the study site ranges from -29°C–38°C with a mean annual 
temperature of 8°C (Spuhler et al. 1971).  Mean regional precipitation ranges from 33–
63.5 cm, including snowfall of 63.5–114 cm (Spuhler et al. 1971).  The prevailing wind 
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direction is from the south in the spring and the north-northwest during the winter.  Wind 
speeds can exceed 80.5 km/h; however, the average annual wind speed in the region is 
17.7 km/h (Spuhler et al. 1971). 
Captive animals were provided fresh alfalfa-grass mixed hay, pelleted soybean 
hulls, water, and loose mineral ad libitum daily.  Capture, transport, daily care and animal 
sampling protocols were reviewed and approved by the SDSU Institutional Animal Care 
and Use Committee (Number 14-076A).  Captive animal care met or exceeded the 
recommendations from the Sikes and Animal Care and Use Committee of the American 
Society of Mammalogists (2016). 
Source Herds 
Uniquely marked free ranging adult bighorn sheep were tested 1 to 7 times to 
classify Movi infection status over a period of up to 4 years by state wildlife agencies in 
Idaho, Oregon, Washington, Nevada, and South Dakota for this study (Appendix A; 
Table 1).  Sheep were captured and transported to SDSU.  These animals were host to 
genetically diverse strains of Movi.  Specifically, sheep from the Hells Canyon 
subpopulations, Asotin (Washington), Lostine (Oregon), and Sheep Mountain (Idaho), 
entered the study with the Movi 404 strain, herein referred to the HC-404 strain.  The 
Black Butte herd within Hells Canyon carried the HC-404 strain from 1995 until a novel 
Movi strain, 393, was detected in 2014 (Cassirer et al. 2017).  We refer to this strain as 
BB-393/HC-404.  Rapid Creek and Badlands herds within South Dakota were exposed to 
the SD-398 strain, and the Snowstorm herd from Nevada entered the study with the Movi 
400 strain and is therefore referred to as NV-400 herein (Table 1).  
7 
Most sheep were of known Movi infection class and strain type when they arrived 
at SDSU and were segregated into pens based on infection status and strain type (Fig. 1).  
Sheep of unknown infection status and strain type were penned together by capture event 
and segregated from other sheep until their carrier status and strain type were confirmed.  
This included sheep that were transferred to SDSU from the Badlands herd (n = 2) in 
2012 and the Snowstorm (n = 11) and Black Butte herds (n = 8) in 2014.  
Experimental design 
Bighorn sheep at SDSU were assigned to pens based on Movi carriage 
characteristics using a switch back design with replicates from 7 source populations and 3 
sheep born in captivity (Table 1).  Sheep were penned together by Movi strain type 
exposure and carriage history (chronic carrier in pen or not). We used carriage history as 
our initial measure of individual host infection response. A minimum distance of 15 m 
between carrier and non-carrier pens was established to minimize the potential for 
pathogen transmission between pens.  Considering the prevailing winds, bighorn sheep 
groups lacking chronic Movi carrier were housed in pens in the western (upwind) edge of 
the research facility (Fig. 1).   
Further, in an effort to prevent any human-assisted transmission of pathogens, 
personnel followed strict biosecurity protocols including: (1) the installation of 
disinfecting foot baths at each pen gate for use immediately prior to entering and exiting 
each pen; (2) use of pen-specific feed and water pails; (3) changing protective clothing 
when handling possible Movi-positive sheep; and (4) use of order-of-entry from west 
(Movi-negatives) to east (Movi-positives; Fig. 1).   
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Microbiological Sampling 
Starting the fall after an individual arrived at the facility, we collected serial 
microbiological samples from all sheep from 1 October–15 March annually, or when 
dependent lambs were no longer present in each pen.  To capture adults for sampling, we 
administered chemical immobilizing agents (BAM; 0.43 mg/kg butorphanol, 0.29 mg/kg 
azaperone, 0.17 mg/kg medetomidine, Wildlife Pharmaceuticals, CO, USA) using a CO2 
powered dart projector (Pneu-dart, Williamsport, PA, USA).  
  For Movi detection in bighorn sheep, we fully inserted single polyurethane culture 
swabs (BD CultureSwabTM EZ System) into both nares and slowly rotated the swab shaft 
while gently contacting the mucosal tissue of the nasal wall and withdrawing the swab 
with circular motions.  Duplicate swabs were collected and stored at -20 C after 
replacement in the sterile sheath prior to submission to the lab for polymerase chain 
reaction (PCR) detection of Movi (Ziegler et al. 2014).  We collected 8-10 ml of blood 
via jugular venipuncture and extracted 0.5–1-ml serum for detection of antibodies to 
Movi via competitive enzyme-linked immunosorbent assay (ELISA) performed by the 
Washington Animal Disease Diagnostic Laboratory (WADDL).  We shipped all samples 
overnight to Dr. Thomas Besser’s laboratory at Washington State University (Pullman, 
WA, USA) for PCR analyses and strain-typing using multi-locus sequence typing 
(Cassirer et al. 2017).  We collected the same samples at mortality and in addition, we 
used bronchial swabs at necropsy to detect and strain-type Movi inhabiting the lower 
respiratory tract. 
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 Clinical observations 
We conducted 20-minute vehicle-based observations using binoculars at distances 
of ≥ 27 m daily from 1 April 2015 to 1 April 2017.  We recorded signs of respiratory 
disease and ranked them from 0–10 to indicate the observed severity ranging from absent 
to extremely severe.  Signs recorded included lethargy, sternal recumbency, ear paresis, 
nose licking, nasal discharge, and coughing for each individual (Appendix B).  From the 
first indication of pneumonia-related symptoms (i.e., presence of minor cough or clear 
nasal discharge), we estimated each individual’s date of infection from a novel cross-
strain transmission event as three-weeks prior to the onset of the initial symptom (Besser 
et al. 2014; Appendix C).  We classified an individual as asymptomatic/recovered if they 
did not present any indication of coughing or nasal discharge for a minimum of 60 days.  
To track disease progression during the cross-strain transmission event, we used daily 
clinical scores for all adults from 16 July 2015–1 April 2017.  
Environmental samples 
To identify potential environmental factors contributing to transmission of Movi 
across pens, we sampled air, water, flying insects, bird nests, and soil.  We also collected 
various opportunistic samples of bird nests and fly traps in pen shelters when possible.  
We conducted aerosol sampling bi-weekly at each of ≥ 5 pens (Sartorius MD8 Airport 
Portable Air Sampler, Fisher Scientific, Waltham, MA, USA) for 20-minutes at 3 defined 
locations: immediately outside and down-wind of the enclosure being tested (<1 m from 
pen fence), halfway between the enclosure being tested and the immediately adjacent 
down-wind pen (halfway from source pen fence), and immediately outside the nearest 
adjacent down-wind pen (15 – 30 m from source pen fence) of the pen being sampled.  At 
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the end of the air sampling period, we placed half of the air filter in 10-ml Hayflick’s 
broth and placed the other half in a sterile storage bag.  We collected weekly drinking 
water samples from the 25-gal trough permanently placed in each pen.  We collected 50-
ml of surface water and then thoroughly mixed the water and collected 50-ml from the 
center of the water trough. We conducted invertebrate (e.g., Musca spp.) contamination 
assessments using fly tape traps and collecting replicate swabs of the external surface of 
trapped flying invertebrates.  Finally, we tested observer-fomite transmission by securing 
gauze to the bottom of work boots and traversing the pen for 5-minutes focusing on areas 
sheep spent the most time (e.g., feed, water stations, shelters).  All environmental 
samples were sent to Dr. Thomas Besser’s laboratory for Movi culture and PCR 
diagnostics. 
Statistical Analyses 
To capture the initial transmission and incubation prior to the epizootic, which 
was first observed 15 July 2015, we initiated our model 1 January 2015 and concluded it 
on 1 April 2017.  To model the disease progression during the cross-strain transmission 
event, we used a Bayesian mixture model for competing risks (Larson and Dinse 1985) to 
estimate the daily probability and daily rate of transitioning to and from disease states and 
to death. This approach assumed all individuals will transition from their current state to 
a new state at some point in time (i.e., probability of staying in its current state as time →
∞ = 0), and the state to which an individual transitions to next was determined by some 
stochastic mechanism when they entered their current state (Larson and Dinse 1985).  
With this structure, individuals exhibited staggered entry into each new state because of 
heterogeneity in transition times due to individual host response.  We also assumed that 
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an individual’s origin for the daily hazard rate of transitioning is the daily interval at 
which they entered a state. 
We modeled the overall probability an individual in state i transitions to state j, 
and then, conditional on this transition, we estimated the associated daily hazard rate of 
making the transition.  Thus, the transition probabilities acted as mixing parameters for 
the various hazard rates.  Using Kermack and McKenrick’s (1927) classic compartmental 
SIR model structure, we developed a model with three main individual disease states: 
susceptible (S; i.e., susceptible to infection), infected (I; i.e., those that were currently 
displaying clinical symptoms of respiratory disease and were presumed infectious), and 
recovered (R; i.e., those who have had the disease but were no longer symptomatic; 
Anderson and May 1991).  We classified all adults as S at the start of our model (1 
January 2015).  Since we did not have real time information on disease status, we 
classified individual disease state based on daily clinical symptoms of respiratory disease.  
We used cough and nasal discharge scores to define disease states.  We defined the start 
of disease state I as 3 weeks prior to the date of the onset of cough (score ≥ 1) or nasal 
discharge (score of > 2) (Besser et al. 2014, Appendix B).  We classified an individual as 
R if they did not present any indication of coughing or nasal discharge (score ≤ 2) during 
daily clinical symptom observations for a minimum of 60 days. 
The model was structured such that I individuals could not return to the S state; 
however, R individuals could return to the I state.  We also included two absorptive states 
(i.e., probability of transitioning from an absorptive state = 0).  The first was death 
unassociated with disease (mortalityo), and individuals could die and enter this state from 
any of the states.  The second was disease-associated death (mortalityp).  Only I 
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individuals could enter this state.  Lastly, individuals that did not die during the study we 
considered to be right-censored in the state they occupied at the study’s conclusion.  The 
model structure is shown in Figure 2.   
Transition Probabilities–We estimated most transition probabilities as a function 




where 𝑝𝑖,𝑗 is the probability of transitioning from state i to j during the study, X is a 
covariate matrix, which varied between transition probabilities, and β are the parameters 
for the covariate effects.  However, individuals transitioning from state I could move to 3 













 are the parameters for the covariates associated with transitioning to state j from 
I.  
Table 2 contains the covariates used for each transition probability.  For the 
probabilities of transitioning from S, (p2), we included an effect for the individual’s 
immune response (Movi cELISA % inhibition value; %I hereafter) prior to cross-strain 
infection as determined by clinical symptoms and subsequent results of PCR and Movi 
strain type testing and the known-Movi exposure (initial strain) of that individual.  For 
the probabilities of transitioning from I, (p3, p4), we included effects for each individual’s 
immune response prior to the cross-strain transmission event, the individual’s immune 
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response during active cross-strain infection, and the individual’s initial Movi strain.  
Lastly, we specified the probability of transitioning back to I from R (disease recurrence; 
p6) as a function of the individual’s initial Movi strain at the start of the study.   
Transition Hazard Rates–We used a piece-wise constant function to model each 




) = X φ + δt, 
where 𝜆𝑖,𝑗,𝑡 is the daily hazard of transitioning from state i to j during daily interval t, 𝜑 
are the parameters for the covariate effects and 𝛿𝑡 is a regularizing term for daily interval 
t, which is used to account for temporal autocorrelation and provide temporal smoothing.  
It is worth noting that we used a constant model for 𝜆𝑖,𝑗,𝑡 where j is non-disease-
associated death regardless of the current state i because this transition hazard rate was 
independent of disease state.  
The δt parameters were only used in modeling hazard rates, and we used a kernel 
convolution model (Higdon 2002) to regularize across days of the study when 
transitioning from S to I and from I to disease-associated death.  The δt parameters were 
held constant for all other transitions.  This modeling approach provided a flexible means 
of accounting for temporal autocorrelation and permits the estimation of the level of 
smoothing supported by the data (Higdon 2002).  For the S to I transition hazard with 













) I [d ≤ 120] × αn , 
which uses a Normal density kernel truncated at 120 days (i.e., days beyond 120 days 
from the t do not influence δt) with a variance of σs
2, distt,n
2  is the squared distance 
between t and the nth knot location, and αn is the latent random day effect at the n
th knot.  
We specified a Gamma (1, 1) for 
1
σs
2 , and a Normal (μ = 0, σα
2) prior for the αn vector of 
effects.  We used a Gamma (1, 1) prior on the precision, 
1
σ2
.  We also calculated the ratio 
of the standard deviations, 
σs
σa
, which provided an assessment of the amount of temporal 
smoothing to random variation in the kernel convolution.  A large ratio (<1) indicated the 
δt effects will be smooth, whereas a small ratio indicated little smoothing and the process 
behaved randomly.  We used the same kernel convolution model for smoothing the 
temporal effects, δt, for the I to disease-associated death transition and once again we 
used a Gamma (1, 1) prior on 
1
σs




Table 3 contains the covariates used in each hazard model.  For the transition 
hazard rate from S to I, (λ2), we included an effect of the individual’s immune response 
prior to active cross-strain transmission, and distance from NV-400 strain pen on the log 
hazard rate.  To model the log hazard of transitioning from I to mortalityp, (λ3), we 
included an effect of the individual’s known immune response prior to cross-strain Movi 
infection, the individual’s immune response to active infection (i.e., Movi serological test 
results averaged from of the time of entry into state I until mortality or the end of the 
study).  For the transition from I to the R state (λ4), we modeled the log hazard to include 
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an effect of the individual’s initial immune response, the individual’s immune response 
during the active cross-strain infection, and the individual’s known initial Movi strain.  
Finally, we modeled the hazard of transitioning back to I from R (i.e., disease recurrence; 
λ6) as a constant.       
Posterior Distribution–Given these probabilities and hazards, the kth individual’s 
transition from state i to j makes the following contribution to the log likelihood, 𝑙𝑙𝑖,𝑗,𝑘: 
lli,j,k = log (pi,j) - ∑ λi,j,t
ri, k
t=ei,k




where ei,k is the k
th individual’s entry time into state i and ri,k is the last time the k
th 
individual was known to be in state i.  Note, this model allows for interval censoring of 
the transition time (i.e., the transition time is only known to have occurred between ej,k 
and ri,k ).  Individuals who are in a non-death state at the end of the study (i.e., right 
censored) contribute the following: 







where the first summation is over the J possible states that can be transitioned to from 
state i, and T is the day the study ended.  To complete our model, we specified diffuse 
Uniform (-100, 100) priors on the intercept/base-line log hazard rate, and Normal (μ = 0, 
σ2 = 100) priors for all covariate parameters used in estimating the transition probabilities 
and the daily hazard rates.  The posterior distribution is then proportional to the sum of 
the log of the prior distributions and the log likelihood.   
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Estimation–We employed JAGS (Plummer 2003) in Program R (R Core Team 
2018) via the R2JAGS package (Su and Yajima 2015) to estimate the posterior 
distributions of our parameters of interest and used Markov Chain Monte Carlo (MCMC) 
methods.  Because our likelihood is in a non-standard format, we used the “zeros trick” 
(Lunn et al. 2013) to permit its use in JAGS.  We ran 3 chains for 100,000 repetitions, 
and removed the first 25,000 iterations for burn-in.  Each chain was started with 
dispersed starting values, and graphical checks were used to monitor for evidence of non-
convergence.   
Simulated population–To determine the potential population-level impacts of 
individual host responses to a disease event like that experienced at the SDSU Captive 
Wildlife Research Facility for a wild bighorn sheep herd, we used the posterior predictive 
distributions for the parameters from the model estimated above to simulate a disease 
event and its progression in a simulated bighorn sheep population.  Specifically, we used 
the last 75,000 posterior draws from our model for each parameter and estimated the 
mean number of bighorn sheep, out of a simulated population of 150, that are in each 
state over 720 days. 
RESULTS 
Outbreak 
We established a captive facility containing 37 bighorn sheep originating from 
seven wild populations with known previous exposures to specific Movi strains in 9 pens, 
4 with Movi chronic carriers and 5 without (Fig. 1). Shortly after the first observed lamb 
pneumonia cases in the pens containing chronic carrier ewes, we observed unexpected 
adult respiratory disease in multiple pens including both pens with and without chronic 
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Movi carriers, frequently associated with infection by Movi strains novel to the bighorn 
sheep within the affected pens.  This outbreak allowed us to investigate individual host 
response to genetically diverse strains of Movi. 
Timing of Lamb vs Adult Pneumonia–In 2015, lambs were born from 24 March – 
21 June and all lambs died from pneumonia or other causes by early August (Appendix 
C).  The onset of clinical signs of lamb pneumonia preceded the detection of pneumonia 
in adults and a cross-strain transmission event.  Clinical signs of pneumonia began with 
the Snowstorm lambs on 28 April 2015.  The Snowstorm lamb mortality occurred in May 
and June at 43 days of age (range = 22 – 87 days; n = 7) and all lambs had expired in that 
pen (Pen 9; Fig. 1, Appendix C) by 28 June 2015.  Comparatively, the onset of lamb 
clinical pneumonia was later in other pens.  In an adjacent pen (Pen 7; Fig. 1, Appendix 
C) the first observation of clinical signs was 27 May 2015 and subsequent mean age at 
mortality was 38 days (range = 27 – 49; n = 2).  The final lamb in Pen 7 expired 14 July 
2015, immediately prior to clinical detection of cross-strain infection in adults.  However, 
the NV-400 strain type detected in the mortality samples for both Pen 7 lambs was not 
expected based on the carrier ewes present and represent the first PCR-confirmed 
indication of cross-strain transmission (Appendix C). 
Near the end of July 2015, we witnessed the unexpected mortality of two 
Snowstorm ewes (Pen 9; Fig. 1).  Cause of death was attributed to a severe acute 
pneumonia and infection with strain NV-400.  Simultaneously, we noticed adults, which 
were previously asymptomatic, in an adjacent pen (Pen 7; HC-404; Fig. 1A) exhibiting 
severe clinical indications of pneumonia immediately after the last lamb expired in that 
pen.  Adult mortalityp may have been attributed to a generally slow transmission between 
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pens (Appendix C).  Subsequent to the index case of clinical pneumonia attributed to 
cross-strain infections in each pen, the median number of days for all adults in the pen to 
display clinical disease was 15 days (range = 9 – 47 days).  Median time between onset of 
clinical symptoms and mortalityp was 126 days (range = 45 – 489 days).   
Clinical observations summary– Observation of clinical symptoms of respiratory 
disease was the basis of the morbidity and infection calculation used in our study.  We 
detected 21 instances of transmissions of the NV-400 strain to sheep previously exposed 
to HC-404, BB-393/HC-404, and SD-398 and 4 transmissions of HC-404 to the sheep 
previously exposed to BB-393/HC-404 and SD-398.  After 1 November 2015, Movi 
strains NV-400 and HC-404 were the only strains detected.  We documented signs of 
respiratory disease in 95% (n = 35) of study animals.  The 95% morbidity rate 
documented exceeds the proportion of individuals that were subsequently documented as 
infected with a novel Movi strain (68%), indicating some bighorn sheep may have 
become symptomatic when only their initial strain could be detected.  Cross-strain 
infections were detected from July – October 2015, and time to detection varied by pen 
assignment but generally moved from east to west, opposite of the prevailing winds, 
within the research facility (Appendix A).  Specifically, 82% (n = 9) of individuals 
entering the study with NV-400 (the Snowstorm bighorn sheep herd) showed clinical 
signs when only their initial strain was detectable.  Only 11% (n = 3) of individuals with 
all other strains were clinically infected by their initial strain immediately prior to cross-
strain infection detection.    
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Health Sampling 
Between February 2015 and December 2016 we collected 2 – 10 nasal swab 
samples from the 37 bighorn sheep in our study (2: n = 1; 3: n = 5; 4: n = 6; 5: n = 1; 6: n 
= 9; 7: n = 6; 8: n = 5; 9: n = 4; 10: n = 1) .  The proportion of Movi-positive individuals 
in health samples pooled monthly increased from 0.19 to 0.83 prior to and during the 
observed respiratory disease epizootic, respectively.  During our study, we confirmed 
pneumonia as the cause of death in 43% (n = 16) of the captive bighorn sheep (Fig. 3).  
Other sources of mortality (24%) were darting complications (n = 2), birthing 
complications (n = 1), West Nile Virus (n = 1), liver hemorrhage (n = 1), fly strike (n = 
1), gastric abscess (n = 1), and euthanasia due to emaciation (n = 1) and injury (n = 1; 
Fig. 3).  At the end of our study, survival was 33%, of which half (n = 6) remained in the 
I state (Fig. 3).   
Environmental Samples 
After detection of cross-strain Movi infections, we initiated sampling to help 
understand potential sources and routes of transmission.  We detected Movi in air, water, 
and invertebrate samples (Table 4).  We identified aerosol Movi downwind of the target 
sampled pen (directly outside of target pen: n = 9, between target pen and nearest 
occupied pen downwind from target pen: n = 1, and outside nearest occupied pen 
downwind from target pen: n = 1).  We documented 9 indeterminate air samples (within 
the occupied pen: n = 2, directly outside of target pen: n = 4, and between target pen and 
nearest occupied pen downwind from target pen: n = 3).   
We detected Movi in 22 water, 5 invertebrate, and 1 permanent fly trap samples.  
We did not detect Movi on the soil surface or in a bird nest constructed in an occupied 
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pen’s shelter (Table 4).  Viable Movi, based on detection of Movi proliferation in broth 
culture, were not detected in any environmental sample.  
Statistical Analyses 
Right Censored Susceptible Adults–One individual carrying HC-404 Movi (e.g., 
always positive by PCR; n = 8) failed to display clinical symptoms of pneumonia during 
our study and was right censored in the S disease state.  One other individual that was 
right censored in the S disease state was a ewe from the Snowstorms that had lacked 
clinical symptoms of pneumonia and was never documented with Movi carriage during 
our study.  All other adults in our study transitioned out of the S disease state. 
Transition from the Susceptible State to the Infected State–Our model indicates bighorn 
sheep are very susceptible to the introduction of a novel Movi strain into the herd.  
Generally, our results indicate a high probability that a previously exposed bighorn sheep 
will become clinically infected when exposed to a novel Movi strain (Fig. 4A).  The 
Movi strain type to which an individual was previously exposed did not affect the 
probability of infection (Table 2).  The initial immune response, defined as the %I value 
at the nearest sampling event (4–7 months) for that individual prior to the 2015 
pneumonia epizootic; %II hereafter), had raw values ranging from 4.25–89.94%.  Effect 
size for median effect of probabilities and daily hazards within are presented on the logit 
and log scale, respectively.  There was a significant effect of %I on the probability of 
becoming infected (median effect size = -10.14; 95% CI = -21.79 – -1.40), with 
individuals with higher pre-existing %II values being less likely to become infected with 
a novel strain.  The probability of being infected was 1.0 for individuals with %II values 
less than 50%, the cutoff for a positive result for the Movi cELISA.  The probability of 
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being infected was nearly 1.0 for individuals with a Movi %II value of 62% inhibition 
prior to the pneumonia outbreak and decreased to 0.5 or less for individuals with %II 
values of 80% or higher (Fig 5). 
The rate at which individual bighorn sheep became infected, defined as the 
infection hazard, was not constant but rather exhibited a bimodal distribution over time.  
Most individuals exhibited disease onset around study day 200 (late July 2015) or 275 
(early October 2015 (λ2; Fig. 6A).  An individual’s %II value did not affect their infection 
hazard (λ2; median effect size = -0.09; 95% CI = -0.45–0.32; Table 3).  Proximity to the 
NV-400 pen (median effect size = -0.31; 95% CI = -0.74 – 0.04) had a marginal effect on 
the infection hazard, with individuals penned closer to the NV-400 pen becoming 
infected sooner than individuals penned farther away; however, this was confounded with 
previous strain exposures since bighorn sheep with the same exposures were penned 
together (Fig. 1).  The ratio of the standard deviation for infection hazard (median effect 
size = 0.71; 95% CI = 0.34–2.03) in the kernel convolution indicated the process exhibits 
more random behavior than a strongly correlated temporal process.   
Transition from the Infected State to the Mortalityp State–Our model presents a 
large degree of uncertainty when estimating the long-term probability of bighorn sheep 
transitioning out of the infected state (Fig. 5b).  From the infected state, one transition is 
to the mortalityp state (Fig. 2).  The covariate effects of %II and previous Movi strain type 
exposure, as well as the indicator variable for NV-400-specific cross-strain transmission 
(CST NV-400) did not have a significant effect on the probability of an infected bighorn 
experiencing mortalityp (Table 2).  However, individuals with higher active immune 
responses (the mean of %I values from the onset of active infection until recovery, if 
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applicable, or mortality; %IA hereafter) during the epizootic were significantly more 
likely to experience mortalityp (median effect size = 3.21; 95% CI = 0.57 – 7.39).  The 
probability of mortalityp for individuals with %IA less than 50% was 0.  The probability 
of mortalityp rose above 0 for %IA above 60% and increased above 0.35 for individuals 
with %IA above 80% (Fig. 7). 
Daily hazard of mortalityp was consistent with most mortality events occurring by 
day 300 of our study (λ3; Fig. 6B).  Mortalityp hazard was not associated with %II 
(median effect size = -0.13; 95% CI = -0.81– 0.84).  In contrast, there was an effect for 
%IA (median effect size = 1.10; 95% CI = 0.18 – 2.23) on mortalityp hazard, with 
individuals with a larger %IA experiencing mortalityp faster than individuals with a lower 
%IA (Table 3).  The ratio of the standard deviation for mortalityp hazard (median effect 
size = 1.17; 95% CI = 0.35–7.12) in the kernel convolution indicated that there was 
evidence that this hazard exhibited evidence of being a temporally correlated process. 
Transition from the Infected State to the Recovered State–Our model predicts the 
probability that an individual remains in the infected state is relatively high (> 0.5) up to 
100 days post-infection; however, our model reflects a greater degree of uncertainly 
thereafter (Fig. 4C), which may be due to a small sample size (n = 8).  Probability of 
recovery was not attributed to %II (Table 2), and individuals experiencing cross-strain 
infection by NV-400 were marginally less likely to recover (median effect size = -7.08; 
95% CI = -18.04–0.50).  In addition, bighorn sheep with a larger %IA were less likely to 
recover from novel Movi strain infection (median = -2.31; 95% CI = -5.52 – -0.05).  
Finally, bighorn sheep that had previous or current exposure to the HC-404 strain were 
more likely to recover to an asymptomatic state following infection by the Movi NV-400 
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strain (HC-404: median effect size = 5.29; 95% CI = 0.42 – 12.66; BB-393/HC-404: 
median effect size = 6.44; 95% CI = 1.21 – 14.51; (Table 2). 
The effect of immune response may drive recovery hazards (λ4), but with varying 
influences.  If an individual were to recover, recovery occurred faster for bighorn sheep 
with increased prior immunity (%II; median effect size = 1.15; 95% CI = 0.10 – 2.43) but 
slower for bighorn sheep experiencing a higher immune response during the active cross-
strain infection (%IA; median effect size = -1.11; 95% CI = -2.28 – -0.20; Table 3).  
Transition from the Recovered State to the Disease Recurrence State–Very few 
individuals experienced disease recurrence in our study (n = 3). Although our sample size 
is small, our model does not suggest differences in the probability of clinical disease 
recurrence based on initial Movi strain exposure histories (p6; Table 2). 
Simulated Population–Our simulated bighorn sheep population model assumed all 
bighorn sheep are susceptible to epizootic pneumonia and that clinical disease may occur 
rapidly (Fig. 8).  A small number of bighorn sheep immediately became infected but 
there was a 4.5-fold increase in number of infected individuals between 120 and 300 
days, which then slightly decreased, resulting in 50% of all surviving bighorn sheep in 
the population remaining infected for the duration of the simulation.  Bighorn sheep 
began to experience pneumonia-related mortality at the 200th simulated day and mortality 
slowly increased until approximately 1/3 of the population had succumbed to respiratory 
disease.  Very few (approximately 25%) bighorn sheep recovered from the infection with 
the novel strain of Movi, and approximately 10% of the simulated population died due to 
non-pneumonia causes over the course of 720 days (Fig. 8).  
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DISCUSSION 
This is the first study to examine individual host response to a Movi strains using 
intensively sampled bighorn sheep with known exposure histories.  We found that adult 
bighorn sheep are highly (95%) susceptible to a novel Movi strain regardless of previous 
exposure history.  However, strains to which an individual was previously exposed may 
influence the outcome following infection: either mortality or recovery.  We described 
ongoing carriage of a pathogenic strain (NV-400) that caused high adult mortality (45%) 
of individuals that were previously infected with it.  Further, for the individuals that 
contracted this pathogenic strain without prior exposure, we describe high (92%) 
mortality rates attributed to pneumonia.  Waning and boosting immunity prior to and 
during outbreaks, respectively, may drive observed heterogeneities in observed adult 
bighorn sheep disease outcomes.  Our study also documents indirect transmission up to 
30 m from infected bighorn sheep, which we hypothesized resulted from aerosolized 
Movi from symptomatic infected bighorn sheep in adjacent pens.  
Strain Type and Competition 
Our study is the first to report multiple cross-strain Movi exposures and 
subsequent disease response from intensively monitored captive bighorn sheep.  Our 
findings support similar conclusions from previous work that suggest that Movi strains 
vary in pathogenicity and that previous strain exposure does not induce immunity to 
novel strains (Felts et al. 2016, Justice-Allen et al. 2016, Cassirer et al. 2017).  Some 
investigators have reported that Movi infections in domestic hosts can result in more 
severe pneumonia when multiple strains are present (Parham et al. 2006, Rifatbegović et 
al. 2011).  The MLST strain typing method characterizes approximately 0.15% of the 
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genome (Cassirer et al. 2017).  Our strain typing method was not able to detect co-
infection unless both strains are at similar concentrations in the sample and are amplified 
for sequencing at similar efficiency.  The MLST strain-typing method used in our study, 
however, has been widely applied in epidemiologic and evolutionary studies.  Kamath et 
al. (2019) validated the strengths of employing this method to describe Movi strain 
diversity and bighorn sheep spillover events from 1984–2017 throughout the western 
United States.  The likelihood and effect of multiple simultaneous Movi strain infections 
in bighorn sheep pneumonia is unknown and warrants investigation.  In addition, it is 
plausible that biologically different strains are included within a single MLST strain type.   
The MLST strain type procedures used in our study indicate all the NV-400 
strains are relatively closely related phylogenetically but provides no information about 
variation in presence or expression of specific virulence genes.  Interestingly, we did not 
detect a cross-strain infection in the Snowstorm herd although they were in close 
proximity to and downwind of the prevailing wind direction to the pens with other strain 
types (Fig. 1).  However, in < 2 years, the Snowstorm bighorn sheep experienced 45% 
adult mortality due to pneumonia. Our findings contrast with observations of relatively 
low levels of adult sporadic mortality following initial exposure (over a period of ≥ 4 
years, approximately 20-25% of adults experienced fatal pneumonia; Smith et al. 2015).   
A possible explanation for the paradoxical observations regarding NV-400 is that the 
genotyping method used to identify Movi strains in this study fails to distinguish multiple 
within-strain variants that may vary in virulence and/or neutralizing surface epitopes.  
Not only did the NV-400 strain usually appear to dominate other strain types once 
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contracted by the host, but 81% (n = 15) of bighorn sheep that died due to pneumonia 
during our study were attributed to NV-400 infections by MLST genotyping.   
Immune Response 
Several findings of this study suggest that adaptive immunity is an important 
factor driving individual heterogeneity in the response of bighorn sheep to disease.  
Immune responses (antibody scores) present prior to the outbreak were associated with 
resistance to outbreak-associated disease, and, if recovery occurred, a faster rate of 
recovery.  However, higher immune responses (antibody scores) during outbreak-
associated disease were associated with both increased probability and hazard of 
pneumonia-induced mortality, and if recovery occurred, with a slower rate of recovery 
(Table 2).   
Generally, immunity is developed during infection of a host, and acts to reduce 
pathogen establishment, survival, reproduction, and/or maturation (Wilson et al. 2002).  
However, immune responses may also be non-protective, ranging from benign non-
neutralizing responses that simply serve as a marker of antigenic exposures associated 
with infection to immunopathological responses associated with adverse reactions and 
increased disease severity (Simenka et al. 1993).  A stronger serum antibody response 
was associated with more severe disease individual hosts (Rattus spp., Mus spp.) 
experimentally infected with Mycoplasma pulmonis.  Further, adaptive immunity did not 
affect recovery of these hosts from chronic mycoplasma infection and disease (Simenka 
et al. 1989, Cartner et al. 1995).  
Our measure of immune response to Movi is a cELISA test, which detects 
antibodies based on their ability to inhibit binding of a Movi-specific monoclonal 
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antibody to Movi antigen in vitro.  The monoclonal antibody used in the assay was 
selected on the basis of immunodominance of its epitope across multiple bighorn sheep 
populations infected by diverse Movi strains, but this epitope has not been shown to be 
involved in protective immunity.  As a result, immune responses as measured by percent 
inhibition (%I) should be considered to primarily reflect the intensity of current or past 
Movi exposure.  Therefore, increased %I may be expected in individual animals unable 
to mount an effective immune response, and consequently are subjected to a higher or 
more sustained pathogen load.  Both beneficial and adverse effects of immune responses 
to Movi infection are plausible: while immune responses may be associated with 
decreased pathogen carriage (Niang et al. 1998, Plowright et al. 2013), strong humoral 
immune responses may induce autoimmune responses in domestic sheep and have been 
hypothesized in wild sheep (Niang et al. 1998, Cassirer et al. 2018).  Cassirer et al. 
(2017) documented adult bighorn sheep that died following cross-strain transmission had 
higher Movi %I prior to the novel strain invasion compared to those that survived 
disease.  Although our study does not support this finding, our study does indicate that a 
potential immune “over-reaction” during, rather than prior to, a novel infection may be an 
important factor driving pneumonia-induced adult bighorn sheep mortality.   
While most individual bighorn sheep that survive infection clear Movi carriage, 
others survive but fail to clear and become chronic carriers that serve as a reservoir to 
sustain the pathogen in the population, despite high immune responses (Cassirer et al. 
2018).  Other Mycoplasma pathogens also are documented to have the ability to persist in 
the face of dramatic immune responses (Simenka 2005).  Lacking a better understanding 
of the interactions between the host’s immune system and Movi virulence factors, the 
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cELISA may fail to distinguish protective from ineffective or harmful immune responses, 
making it difficult to interpret its effects when evaluating bighorn sheep management and 
recovery from a pneumonia epizootic. 
It is generally accepted that immune responses are genotype-specific, with 
previously unseen genotypes having a growth advantage in semi-immune hosts (Simenka 
2005).  Our study reflects this complex notion in which individual bighorn sheep that had 
stronger immune responses following previous Movi exposure were less likely to exhibit 
disease symptoms (Table 2), and experienced shorter recovery times (Table 3).  The 
majority (67%; n = 6) of bighorn sheep that recovered, however, were challenged by their 
initial strain or a strain that they had previously been exposed to in the wild (NV-400 or 
BB-393/HC-404, respectively).  In contrast, only 13% (n = 3) of bighorn sheep that 
experienced a novel cross-strain transmission event recovered in our study.   
Simulated Population 
In Hells Canyon (Idaho, Washington, and Oregon, USA), a minimum of 34 
pneumonia events occurred in these interconnected populations over a 14-year period, 
including invasion episodes that resulted in high all-age mortality followed by recurring 
epizootics mostly in juveniles (Plowright et al. 2013).  Post-invasion dynamics were 
characterized by sporadic adult mortality and variable but usually high mortality in 
lambs.  Mortality events following Movi invasion ranging from 30–50% are common 
(Jorgenson et al. 1997, Cassirer et al. 2013, Plowright et al. 2013).  The fates of 
individuals in our study (Fig. 4) and simulated models (Fig. 8) agree with these previous 
conclusions. 
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The simulated population model reported here was developed to offer insight 
regarding potential effects of a novel Movi strain introduction in a previously exposed 
wild herd if the herd responded similarly as our captive bighorn sheep.  Our simulated 
model suggests approximately one-half of the population will remain symptomatic for 2 
years following introduction of a novel strain (Fig. 8).  This contradicts many 
observations following natural infections (e.g., Yakima Canyon where 97% (n = 34) 
recovered within 2 years; Bernatowicz et al. 2016); however, it is unclear if any 
individuals remained symptomatic.  Healthy periods (years) typically occur in exposed 
free-ranging populations (Cassirer et al. 2013, Plowright et al. 2017).  Bighorn sheep 
disease response and expression are complex and, in part, may be explained by 
differences among Movi strain types, other secondary infections, and non-infection-
related factors (e.g., sinus tumors; Fox et al. 2015).  Social behaviors that would regulate 
frequency-dependent transmission following recovery could facilitate protection of some 
groups following disease outbreaks (Manlove et al. 2014) and may be an important 
mechanism driving recovery of bighorn sheep. 
In free-ranging populations, state transitions may differ than presented in our 
conclusions as host contact patterns and dose associated from contacts are likely to be 
driving factors attributed to heterogeneity in disease response.  The stochasticity of 
disease occurrence rates presented here are likely due to the initial infection in most pens 
occurred via indirect transmissions (i.e., one individual becoming infected in a pen) 
followed by direct contact with that newly highly infectious individual (i.e., pathogen 
transmission throughout the pen; [Fig. 6A]).  Pens closest to the Snowstorm bighorn 
sheep became infected and experienced mortality before the more distant pens in our 
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study.  In general, once one individual expressed clinical symptoms of novel strain 
infection, the remainder of the individuals in the pen quickly followed (Appendix C).  
The rapid spread and exposure of nearly all individuals in novel Movi invasion events has 
previously been reported (Cassirer et al. 2017).  Recovery from disease invasion may be 
slow (Fig. 8) but persistent carriage could last ≥ 3 years (Plowright et al. 2017).   
Environmental Factors 
We detected Movi in aerosol, fly, and water samples although we were unable to 
culture viable organisms from these samples.  This is likely due, at least in part, to the 
fastidious nature and rapid death of Movi outside of the mammalian host.  A future study 
that immediately inoculates aerosolized droplets into culture broth is needed.  In spite of 
careful planning and consideration of prevailing winds, we believe the most likely 
mechanism of cross-strain transmission experienced during our study is Movi on 
aerosolized droplets.  Besser et al. (2014) reported Movi transmission to all yearling 
captive bighorn sheep by a single source within and between pens up to 12 m distant. 
Although average wind direction was generally opposite to pen-to-pen transmissions 
(Appendix C), wind direction frequently varied and wind speeds of > 60 km/h were 
common; wind gusts >100 km/h that occurred in late June and early August may have 
facilitated rapid movement of droplets containing viable bacteria across the facility 
(Appendix D).  We detected aerosolized Movi DNA at the boundary of the nearest 
downwind pen at the maximum range tested (30 m) from infected bighorn sheep.   
Closely related Mycoplasma spp. infectious agents have been recognized as viable 
and transmissible through aerosolization.  M. hyopneumoniae, which causes atypical 
pneumoniae in swine (Stärk et al. 1998, Desrosiers 2011), has been documented to be 
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transmissible via aerosol droplets 9.2 km from the infected source pen (Otake et al. 
2010).  In addition, M. bovis, the primary agent in cattle pneumonia epizootics, and M. 
synoviae and M. gallisepticum, which cause acute or chronic respiratory disease in 
poultry, respectively, can infect livestock by airborne pathogen transmissions (Landman 
et al. 2010, Kanci et al. 2017).  Furthermore, secondary Pasteurellaceae agents are 
transmissible through aersolization up to 18 m (Dixon et al. 2002) as well as by fomite 
contamination (Burriel 1997, Clifford et al. 2009). 
Our study is the first to document flies (Musca spp.) as a possible vector of 
transmission for Movi in bighorn sheep infections.  Some fly species feed on nasal and 
oral discharge and have been implicated in the rapid spread of similar agents, including 
M. conjunctivae, which causes infectious keratoconjunctivitis in wild and domestic 
Caprinae (Degiorgis et al. 1999, Giacometti et al. 2002, Fernandez Aguilar et al. 2019).  
Permanent fly traps were secured to the roof of shelters where symptomatic bighorn 
sheep spent a considerable amount of time, particularly as disease progressed.  The 
positive Movi detection of the permanent fly trap could be the result of airborne particles 
expelled during coughing.  However, the Movi-positive fly tape was a direct sample of 
flies and offers strong evidence as a possible route of transmission in captive studies.  
Furthermore, the strain-type that was identified directly from flies (SD-398) had never 
been detected in bighorn sheep carriage in that pen (Pen 1).  Additional investigations 
aimed at detecting transmissible and viable Movi from flies that feed on oronasal 
secretions are necessary to better understand the effect of vector-borne Movi transmission 
in bighorn sheep epizootics.  
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Other Possible Sources of Contamination 
Similar to other studies, under established biosecurity protocols, personnel who 
were in daily contact with infected bighorn sheep were not a likely mechanism of Movi 
cross-strain transmissions (Goodwin 1985, Batista et al. 2004).  Anthropogenic (e.g., 
clothing) and other fomites (e.g., feed buckets) may serve as pathogen carriers that could 
result in Movi contamination and merit consideration.  We most often detected Movi in 
water samples (Table 4) and observed various avian species (e.g., Sturnus vulgaris) 
frequenting these established sites.  Due to the failure to detect Movi in a frequently 
visited nest within an infected pen, we assume that it is unlikely that birds following 
contact with contaminated water present a risk of Movi transmission.  We caution 
investigators that Movi transmission or contamination may be possible via shared 
contaminated water, especially in captive studies, but further investigation is 
recommended.     
Study Limitations 
We did not intend to evaluate novel Movi strain invasions of bighorn sheep.  As 
such, the experimental design for our original study objective limited our individual 
disease measurements to clinical observations for much of our study.  However, when 
capture and direct pathogen testing allowed, our disease state classifications based on 
clinical observations concurred with 94% of all PCR and serological analyses.  Further, 
we assumed a model start date of 1 January 2015 was appropriate to capture “pre-
outbreak” disease dynamics (e.g., disease state S in our model).  Although clinical 
observations were conducted daily immediately upon arrival at our captive facility, we 
did not record intensive daily individual adult disease symptoms until 15 July 2015.  
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Adult general health notes were frequently documented prior to the index case of adult 
disease on 15 July 2015.  Therefore, we may have misclassified the true date of becoming 
infected, particularly for the two Snowstorm adults that experienced pneumonia-induced 
mortalityp in late July 2015.  Further, as described above, a lack of detection does not 
completely rule out that a given strain was not actually present.  Lastly, the covariates 
used to explain contribution to disease processes for a dose effect (e.g., distance to Pen 9 
[Snowstorm bighorn sheep]; Fig. 1) and strain histories are confounded and the 
unexpected mortality in Pen 9 suggests that dose may contribute to disease severity.  A 
better understanding is needed of how dose and exposure history influence response to 
infection.  
MANAGEMENT IMPLICATIONS 
Bighorn sheep are extremely susceptible to Movi infection, and direct contact 
does not appear to be necessary for transmission when animals are symptomatic, which is 
an important consideration for captive and free-ranging bighorn sheep research and 
management.  Cross-strain infections may produce similar morbidity and mortality 
patterns as the initial invasion of Movi into naïve bighorn sheep populations.  
Understanding Movi exposure histories and minimizing exposure to new strains is critical 
to successful management strategies.  Further, some strains of Movi appear to cause more 
disease than others.  Studies that explore the interactions between the immune system and 
Movi virulence factors may provide important insights for understanding heterogeneity in 
bighorn sheep responses to infection.  
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Table 1. South Dakota State University captive bighorn sheep source herds, Mycoplasma 
ovipneumoniae genotypes (strain) detected in those herds, and number of adult bighorn 
sheep used in our study. 
 
Source Herd Movi Strain Strain Abbreviation n 
Hells Canyon    
      Asotin 404 HC-404 9 
      Lostine 404 HC-404 4 
      Sheep Mountain 404 HC-404 2 
      Black Butte 393/404 exposed BB-393/HC-404 8 
South Dakota    
      Rapid Creek 398 SD-398 1 
      Badlands 398 SD-398 2 
Nevada    
      Snowstorm 400 NV-400 11 
    
















Table 2. Estimated posterior distribution of disease state transition probabilities (pn) as a 
function of covariates using a logit link function for state transitions susceptible to 
infected (S-I) and disease recurrence (R-I) and a multinomial logit model for individuals 
transitioning from the infected state: infected to pneumonia-related mortality (I-
Mortalityp) and infected to recovered (I-R).  Median effect of disease state transitions are 
presented on the logit scale, and 95% lower credible limit (LCL) and upper credible limit 
(UCL) are presented. 
State Transition Predictor   Median  95% LCL 95% UCL Significant 
S-I (p2) Intercept  9.44 2.47 25.00  
 
%IIƗ  -10.14 -21.79 -1.40 * 
 Initial Strain      
 NV-400 - - -   
 HC-404 8.09 -5.36 23.18   
 BB-393/HC-404 1.02 -12.93 10.71   
 SD-398 8.84 -5.08 23.94   
I-Mortalityp (p3) Intercept  -2.03 8.76 -14.35  
 
%II  -0.40 -2.95 1.53  
 
%IAƗƗ  3.21 0.57 7.39 * 
 CST NV-400
ƗƗƗ  3.76 -6.94 16.05  
 Initial Strain      
 NV-400 - - -   
 HC-404 0.32 -3.69 4.61   
 BB-393/HC-404 -1.71 -6.07 2.34   
 SD-398 6.29 -3.27 22.3   
I-R (p4) Intercept  2.32 -7.01 13.40  
 
%II  1.48 -1.31 4.66  
 
%IA  -2.31 -5.52 -0.05 * 
 CST NV-400  -7.08 -18.44 0.50  
 Initial Strain      
 NV-400 - - -   
 HC-404 5.29 0.42 12.66 * 
 BB-393/HC-404 6.44 1.21 14.51 * 
 SD-398 -1.59 -20.16 14.14   
47 
R-I (p6) Intercept  5.32 -0.04 16.14  
 Initial Strain      
 NV-400 - - -   
 HC-404 0 0 0   
 BB-393/HC-404 -5.49 -16.33 0.27   
 SD-398 0 0 0   
       
Ɨ indicates initial percent inhibition values per individual, defined as the quantification of Movi antibody 
titers prior to cross-strain transmissions (disease state S (Susceptible), prior to 15 March 2015), used to 
evaluate immune response to epizootic pneumonia. 
ƗƗ indicates average percent inhibition values per individual, defined as the quantification of an individual’s 
immune response to active Movi infection, from the onset of active cross-strain infection (earliest 15 March 
2015) until the remainder of the study. 
ƗƗƗ indicates confirmed indicator variable due to cross-strain transmission with NV-400 by multi-locus 




Table 3. Estimated posterior distribution of daily disease state transition hazard (λn) as a 
function of the covariates of interest using a piece-wise constant function.  State 
transitions presented are susceptible to infected (S-I), infected to pneumonia-related 
mortality (I-Mortalityp), and infected to recovered (I-R).  Hazard rates are presented on 
the log scale, and 95% lower credible limit (LCL) and upper credible limit (UCL) are 
given. 
 
State Transition Covariate   Median 95% LCL 95% UCL Significant 
S-I (λ2) %IIƗ 
 -0.09 -0.45 0.32  
 Distance
ƗƗ  -0.31 -0.74 0.04  
I-Mortalityp (λ3) %II 
 -0.13 -0.81 0.84  
 %IA
ƗƗƗ 
 1.10 0.18 2.23 * 
I-R (λ4) %II 
 1.15 0.10 2.43 * 
 %IA 
 -1.11 -2.28 -0.20 * 
 Initial Strain 
    
 NV-400 
- - -   
 HC-404 0.00 0.00 0.00   
 BB-393/HC-404 1.46 -1.00 4.91   
 SD-398 0.00 0.00 0.00   
              
  
     
Ɨ indicates initial percent inhibition values per individual, defined as the quantification of Movi antibody 
titers prior to cross-strain transmissions (disease state S (Susceptible), prior to 15 March 2015), used to 
evaluate immune response to epizootic pneumonia. 
ƗƗ measure of proximity (m) of assigned pens (Pens 1 – 8) to the NV400 Pen, Pen 9 (Fig. 2). 
ƗƗƗ indicates average percent inhibition values per individual, defined as the quantification of an individual’s 
immune response to active Movi infection, from the onset of active cross-strain infection (earliest 15 March 
2015) until the remainder of the study. 
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Table 4. Mycoplasma ovipneumoniae prevalence in environmental samples used to 
identify possible modes of cross pen transmission in our study. 
 
Sample n Movi P Movi I Movi N 
Air 191 0.08 0.05 0.87 
Water 167 0.13 0.01 0.86 
Fly tape 66 0.02 0.09 0.89 
Fly trap 2 0.50 0.00 0.50 
Avian nest 2 0.00 0.00 1.00 
Boots 2 0.00 0.00 1.00 
          
 
where: 
Movi P indicates proportion of positive detection of Movi in samples during PCR analysis 
(CT ≤ 35.0); range = 29.4–35.0. 
Movi I indicates proportion of indeterminate detection of Movi in samples during PCR 
analysis (CT = 35.01-39.9); range = 35.4 – 37.3. 
Movi N indicates proportion negative detection of Movi in samples during PCR analysis (CT 





Figure 1. Captive bighorn sheep research facility design and pen assignments based on 
known-Mycoplasma ovipneumoniae history and current carriage as of 1 January 2015 
(A).  Unintentional indirect novel Mycoplasma ovipneumoniae strain infections as of 1 
January 2016 (B). Strain types listed as 404 is HC-404, 400 is NV-400, 398 is SD-398, 
and 393 is BB-393/HC-404.  A (+) indicates Movi detected in pen and (-) indicates Movi 












































































p1, λ1 = probability, hazardƗ, respectively, of non-pneumonia-related (other) mortality of susceptible individuals  
p2, λ2 = probability, hazard of being infected (explicitly defined as displaying clinical symptoms of respiratory disease)  
p3, λ3 = probability, hazard of pneumonia-related mortality  
p4, λ4 = probability, hazard of recovery  
p5, λ5 = probability, hazard of non-pneumonia-related (other) mortality of infected individuals 
p6, λ6 = probability, hazard of disease recurrence  











p7, λ7 = probability, hazard non-pneumonia-related (other) mortality of recovered individuals 
Ɨ Hazard is defined as the daily rate at which individual bighorn sheep transition from one disease state to another. 
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Figure 3. Fate of 37 adult captive bighorn sheep during our study.  For individuals that 
died, Mycoplasma ovipneumoniae (Movi) detection at mortality is reported.  Mortalityp 
indicates instances of pneumonia-related mortality.  Mortalityo indicates instances of non-
pneumonia-related (other) mortality.  For individuals that survived during our study, 
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Figure 4. Results of a multi-state mixture model of competing risks estimating the 
probability an individual remains in the following states during a novel cross-strain 


















Figure 5. Covariate effect of initial Movi percent inhibition(%II) prior to the cross-strain 
transmission outbreak on the probability of individual bighorn sheep becoming infected 
with Movi (p2).  Raw %II values were standardized by subtracting the mean (?̅? = 62.12%) 
and dividing by the standard deviation (SD = 25.60%) of %II values for each individual.  





Figure 6. Predicted posterior distributions on the log scale of daily state transition hazards 
of (A) being infected by pneumonia and (B) pneumonia-related mortality before, during, 













Figure 7. Covariate effect of the mean active Movi percent inhibition (%I) during the 
cross-strain transmission (%IA) on the probability of individual bighorn sheep dying of 
Movi-induced respiratory disease (e.g., Mortalityp; p3). Raw %IA values were 
standardized by subtracting the mean and dividing by the standard deviation of %IA 











Figure 8. Predicted disease progression in a simulated wild bighorn sheep population (n = 
150) using the posterior predictive distributions for the parameters describing the cross-
strain transmission event in the captive bighorn sheep study (A).  We assume the index 
case of cross-strain infection initiates the disease simulation on Day 1.  Total simulated 
population size is presented over the course of the epizootic for a simulated wild bighorn 
















APPENDIX A. BIGHORN SHEEP SOURCE HERDS 
Wild bighorn sheep source herds selected for translocation to the South Dakota State 




APPENDIX B. DAILY CLINICAL SYMPTOMS SCORING 
 
Adult Respiratory Disease Scoring Sheet 
 
            
  Dam #       
     
Sire #     
  DOB       
        
  Sex: (Circle) Male 
   
Female 
    
            







        
VISUAL ASSESSMENTS:     
1. Inappetence  5. Droopy Ears 
2. Lethargy  6. Nose Licking 
3. Cough  7. Weakness/Recumbancy 
4. Nasal Discharge  8. Head Shaking 
 
Date 1 2 3 4 5 6 7 8 Score Scorer Notes 
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APPENDIX C. PNEUMONIA OUTBREAK DETAILS 
Pen assignments, onset of clinical symptoms, and fates of captive bighorn sheep adults 
relative to lambs experiencing endemic pneumonia in 2014 and the pneumonia outbreak 
attributed to cross-strain Movi infections in 2015 (all-age mortality).  Known cause of 
mortality includes pneumonia-induced mortality (Mortalityp) or other, non-pneumonia-
induced mortality (Mortalityo).  Endemic Movi strains are provided and identified with 
pen numbers.  Chronic carrier adults are identified with a “C” within individual figures 
below.  Gray figures indicate failure to detect a novel Movi strain within the specified 
year (i.e., endemic Movi strain caused Mortalityp), and the black figures indicate the 
detection of a novel Movi strain at least once within the year (i.e., cross-strain infection) 










































































Pen 7: HC-404 




























                                                                           
Affected: 8/13/15                                              
Died: NA                                                           
Cause: NA                                                         




Cause: Mortalityp  
Strain: HC-404 
                                                                           
Affected: 7/16/15                                              
Died: NA                                                           
Cause: NA                                                         




Cause: Mortalityo  
Strain: NA 
                                                                           
Affected: 7/15/15                                              
Died: NA                                                           
Cause: NA                                                         




Cause: Mortalityp  
Strain: HC-404 
                                                                           
Affected: 8/2/15                                                
Died: NA                                                           
Cause: NA                                                         



















Pen 4: SD-398  
                                                                          
Affected: 8/17/15                                                          
Died: NA 
Cause: NA                                                         
Strain: HC-404                                                  
Pen 3: HC-404 
                                                                          
Affected: 7/29/15                                              
Died: NA                                                           
Cause: NA                                                         




Cause: NA  
Strain: HC-404 
                                                                          
Affected: 9/3/15                                                
Died: NA                                                           
Cause: NA                                                         




Cause: Mortalityp  
Strain: HC-404 
                                                                          
Affected: NA                                                    
Died: NA                                                           
Cause: NA                                                         




















   
Pen 6: SD-398 
                                                                          
Affected: 8/18/15                                                          
Died: NA                                                           
Cause: NA 
Strain: NV-400                                                  
                                                                          
Affected: 8/16/15                                                           
Died: 11/13/15                                                           
Cause: Mortalityp                                                         
Strain: NV-400                                                  
 
C 
Pen 5: BB-393/HC-404 Exposed 
                                                                          
Affected: 11/12/15                                           
Died: NA                                                           
Cause: NA                                                         




Cause: Mortalityo  
Strain: NA 
                                                                          
Affected: 8/18/15                                              
Died: NA                                                           
Cause: NA                                                         




Cause: NA  
Strain: NA 
 
Affected: 9/14/15                                             
Died: NA                                                           
Cause: NA                                                         




























Pen 7: HC-404  
Affected: 7/8/15                                                           
Died: NA                                                           
Cause: NA                                                         
Strain: NV-400                                                 
Affected: 7/9/15                                                          
Died: NA                                                           
Cause: NA                                                         
Strain: NV-400                                                 
Affected: 7/17/18                                                          
Died: NA                                                           
Cause: NA                                                         
Strain: NV-400                                                 
 
Affected: 6/15/15                                                           
Died: 9/3/15                                                           
Cause: Mortalityp                                                        
Strain: NV-400                                                 
                                                                          
Affected: 6/1/15                                                
Died: 8/19/15                                                    
Cause: Mortalityp                                                     






Cause: Mortalityp  
Strain: NV-400 
                                                                          
Affected: 7/24/15                                              
Died: 10/2/15                                                     
Cause: Mortalityp                                                      
































Pen 8: HC-404 




Cause: NA  
Strain: NV-400 
                                                                   
Affected: 8/1/15                                                
Died: 12/3/15                                                     
Cause: Mortalityp                                                      
Strain: NV-400                                                  
 
C 
Affected: 8/1/15                                                           
Died: 12/8/15                                                           
Cause: Mortalityp                                                         
Strain: NV-400                                                 
 
C 
Affected: 8/9/15                                                          
Died: 11/13/15                                                          
Cause: Mortalityp                                                         
Strain: NV-400                                                 
 
C 
Affected: 8/15/15                                                          
Died: 12/3/15                                                          
Cause: Mortalityp                                                         
Strain: NV-400                                                 
 
C
Affected:5/16/15                                               
Died: 12/11/14                                                  
Cause: Mortalityo                                                     




Cause: Mortalityo  
Strain: NA 
                                                                          
Affected: 4/15/15                                             
Died: 10/26/15                                                  
Cause: Mortalityo                                                     









Cause: Mortalityp  
Strain: NV-400 
Affected: 5/30/15                                              
Died: NA                                                           
Cause: NA                                                         






























Pen 9: NV-400 (continued) 
                                                                          
Affected: 5/14/15                                                          
Died: NA                                                           
Cause: NA                                                         
Strain: NV-400                                                  
                                                                          
Affected: NA                                                           
Died: NA                                                           
Cause: NA                                                         
Strain: NV-400                                                  
                                                                          
Affected: 5/30/15                                              
Died: 7/28/15                                                    
Cause: Mortalityp                                                      




Cause: Mortalityp  
Strain: NV-400                                                                           
Affected: NA                                                    
Died: NA                                                           
Cause: NA                                                         




Cause: Mortalityp  
Strain: NV-400 
Affected: 8/18/15                                              
Died: NA                                                           
Cause: NA                                                         




Cause: Mortalityp  
Strain: NV-400 
Affected: 5/24/15                                              
Died: NA                                                           
Cause: NA                                                         





Cause: Mortalityp  
Strain: NV-400 
Affected: 1/13/15                                              
Died: 7/17/15                                                     
Cause: Mortalityp                                                      





Cause: Mortalityp  
Strain: NV-400 
Affected: 5/30/15                                              
Died: 8/18/15                                                     
Cause: Mortalityo                                                      








APPENDIX D. WIND SPEED 
Average daily wind speed and maximum wind gusts (km/h) recorded in Brookings, South Dakota, USA during early 


























CHAPTER 2: INVESTIGATING THE ROLE OF CHRONIC MYCOPLASMA 
OVIPNEUMONIAE CARRIERS IN PNEUMONIA PERSISTENCE AND SURVIVAL 





This chapter is being prepared for publication and was coauthored by Daniel P. Walsh, 




Mycoplasma ovipneumoniae (Movi)-induced pneumonia is a devastating 
respiratory disease that has been implicated as the principal impediment to bighorn sheep 
(Ovis canadensis) recovery for almost a century.  Population-level effects of pneumonia 
events range from mild to extirpation.  Perhaps the greatest bighorn sheep recovery 
concern, however, is recurrent annual lamb epizootics.  We tested the hypothesis that 
respiratory disease persistence within bighorn sheep populations is driven by chronically 
Movi infected ewes, and its prediction that lambs born in pens with at least one chronic 
carrier ewe (treatment) will experience Movi-induced pneumonia mortality whereas 
lambs born in pens without a chronic carrier ewe (control) will not develop fatal 
pneumonia.  All lambs in treatment pens that survived > 10 days of age developed 
respiratory disease, and 92% (n = 24/26) of these lambs experienced fatal Movi-induced 
pneumonia.  During persistent epizootic years of pneumonia, lambs born in control pens 
failed to develop fatal pneumonia and 89% (8/9) survived.  During an all-age pneumonia 
epizootic, total lamb mortality was 88% (22/25).  Movi-induced pneumonia caused 59% 
(n = 13/22) of these mortalities and included 2 lambs in a single control pen.  Non-
pneumonia causes of lamb mortality were high (41% (n = 9/22)) during the all-age 
epizootic, particularly for lambs < 10 days of age.  Our models predicted the probability 
of fatal pneumonia for lambs in treatment pens during all years (2014–2017) of our study 
was >0.90 for two age periods:16–45 and 105–114 days after parturition.  Further, the 
age-varying log hazard of fatal pneumonia was at least twice as high for lambs in 
treatment pens compared to lambs in control pens.  It appears identification and removal 
of chronic carriers from a population will aid bighorn sheep recovery efforts. 
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INTRODUCTION 
Pneumonia is a devastating respiratory disease that has been implicated as the 
principal impediment to bighorn sheep (Ovis canadensis) recovery for almost a century.  
Pneumonia has caused 75–100% mortality in some herds across western North America 
(Rush 1927; Shannon et al. 2014; Sells et al. 2015; Cassirer et al. 2018).  The primary 
pathogen involved in bighorn sheep pneumonia epizootics is Mycoplasma ovipneumoniae 
(Movi; Besser et al. 2008, Dassanayake et al. 2010, Besser et al. 2013).  Movi is a native 
microparasite of Old-World Caprinae, (e.g., domestic sheep (O. aries) and goats (Capra 
hircus)), and these reservoir hosts typically carry infectious agents asymptomatically.  
Contact with reservoir hosts precedes spillover epizootics (Foreyt and Jessup 1982, 
Foreyt et al. 1994, George et al. 2008), and Movi has consistently been identified in fatal 
bighorn sheep epizootics (Besser et al. 2012b, Besser et al. 2013, Cassirer et al. 2017).  
Alternatively, captive bighorn sheep survive when commingled with Movi-negative 
domestic sheep (Besser et al. 2012a, Kugadas 2014).  
Pneumonia epizootics outwardly exhibit high all-age morbidity (Besser et al. 
2014, Cassirer et al. 2017) and mortality.  Cassirer et al. (2018) reported a median 
population decline of approximately 50% (range 5–100%) for 82 bighorn sheep 
pneumonia events.  Bighorn sheep that survive epizootic pneumonia are generally 
believed to be resistant to disease and may become healthy, but a small proportion 
(median = 22%; Cassirer et al. 2018) may maintain or tolerate disease and persistently 
carry Movi (Cassirer et al. 2013, Plowright et al. 2013).  Pathogens usually persist, 
presumably by chronic carriers, in free-ranging populations (Plowright et al. 2017, 
Garwood et al. 2020).   
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Bighorn sheep epizootic pneumonia is characterized by recurrent summer lamb 
mortality.  Pneumonia-induced lamb mortality between 4 and 14 weeks of age is common 
and may last decades following the initial spillover infection (Singer et al. 2000, 
Sirochman et al. 2012, Cassirer et al. 2013, Plowright et al. 2013, Manlove et al. 2014).  
Outbreaks likely start with vertical transmission of pathogens from chronically infected 
carrier ewes to their lambs (Hobbs and Miller 1992, Clifford et al. 2009, Cassirer et al. 
2013), and subsequent lamb-to-lamb transmission within social nursey groups (Manlove 
et al. 2014).  Failure of lamb recruitment triggered by sustained recurrent lamb epizootics 
result in declining and aging herds and may serve as the single most critical management 
concern affecting bighorn sheep populations.  
Several studies have documented negligible to catastrophic effects of recurrent 
pneumonia-induced lamb mortality (Cassirer and Sinclair 2007, Smith et al. 2014, Butler 
et al. 2018), but the causal mechanisms are inadequately understood.  We attempt to 
address this crucial knowledge gap in the first longitudinal, empirical study using captive 
individuals collected from several wild populations (Fig. 1), each with unique known-
Movi exposure histories (e.g., strains; Table 1).  We present evidence of pneumonia 
recurrence and mortality of bighorn sheep lambs during pneumonia epizootics that was 
generally limited to lambs, herein lamb epizootic, which occurred in 2014, 2016, and 
2017.  We compare disease dynamics in these years to an all-age epizootic in 2015.   
We hypothesized that respiratory disease could persist in a bighorn sheep 
population through a small number of Movi carriers that drive disease transmission to 
lambs.  To test this hypothesis, we measured the effect of ewes of differing carrier status 
on the health and survival of lambs.  Our prediction was that lambs born in pens with at 
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least 1 chronic Movi carrier ewe present (treatment) were more likely to show signs of 
pneumonia and have lower survival than lambs born in pens without at least 1 chronic 
Movi carrier ewe (control). 
METHODS 
Study Area 
Our study was conducted at the South Dakota State University (SDSU) Captive 
Wildlife Research Facility in Brookings, South Dakota (44°20´ N, 96°47´ W) ) using 39 
adult bighorn sheep ewes transported from free-ranging populations in Washington (n = 
15), Oregon (n = 5), Idaho (n = 2), South Dakota (n = 3) and Nevada (n = 14) and 
animals ≥2 years of age (n = 10) born in captivity.  Annual temperatures in the region 
commonly vary from -29°C–38°C in the winter and summer, respectively, with a mean 
temperature of 8°C annually (Spuhler et al. 1971).  Mean regional precipitation ranges 
from 33–63.5 cm, with snowfall varying from 63.5–114 cm (Spuhler et al. 1971).  The 
prevailing wind direction is from the south in the spring and the north-northwest during 
the winter.  Wind speeds can exceed 50 mph in the summer and winter, however, the 
average annual wind speed in the region is 11 mph (Spuhler et al. 1971). 
Captive animals were provided fresh alfalfa-grass mixed hay, pelleted soybean 
hulls, water, and loose mineral ad libitum daily.  Capture, transport, daily care, and 
animal sampling protocols were reviewed and approved by the SDSU Institutional 
Animal Care and Use Committee (Number 14-076A) and state wildlife departments.  
Captive animal care met or exceeded the recommendations from the Sikes and Animal 
Care and Use Committee of the American Society of Mammalogists (2016).   
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Pre-study Sampling and Carrier Classifications  
Prior to the initiation of our study, state wildlife departments routinely monitored 
uniquely marked bighorn sheep for Movi prevalence in their respective wild herds.  State 
agency personnel collected nasal and oropharyngeal swabs and sent samples to the 
Washington Animal Disease Diagnostic Lab (WADDL) for analysis.  Using the state 
wildlife department’s data, we reviewed available Movi PCR test results on nasal swabs 
to assign individual sheep to an initial Movi carrier class prior to translocation to SDSU 
(Appendix A).  We classified individual sheep as negative (N), intermittent (I), or chronic 
carrier (C), where N, I, or C classifications were based on that individual testing positive 
for Movi 0%, 1–74%, or ≥ 75% of the time, respectively.   
Following review and identification of individual bighorn sheep eligible for our 
study, state wildlife departments selected and captured adults via chemical 
immobilization or helicopter net-gunning from 7 source herds: Asotin, Black Butte, 
Lostine, and Sheep Mountain (Hells Canyon Washington, Oregon and Idaho), Badlands 
(South Dakota), Rapid Creek (South Dakota), and Snowstorm Mountains (Nevada; Fig. 
1, Table 1) and immediately transported animals to SDSU and released them into a pen.  
Captive Research Facility Design 
Free-ranging bighorn sheep populations often have unique Movi strain exposure 
histories (Cassirer et al. 2017, Cassirer et al. 2018).  To prevent cross-strain 
transmissions, we did not commingle adults from populations where different strains had 
recently been detected.  Considering the prevailing winds, we assigned negative sheep 
pens to the west end of the research facility (Fig. 2).  We designed our captive bighorn 
sheep research pens so that pens were a minimum distance of 15.24 m where possible, 
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particularly between Movi-positive and negative sheep (Fig. 2a).  Further, we followed 
strict biosecurity measures in an effort to prevent cross-strain transmissions including: (1) 
the installation of disinfecting foot baths at each pen gate for use immediately prior to 
entering and exiting each pen; (2) designation of feed and water pails specific to pen 
assignment; (3) changed protective clothing when handling possible Movi-positive sheep; 
and (4) entered pens strictly from west (Movi-negatives) to east (Movi-positives) daily 
and consistently as pens were numbered (e.g., Pen 1 first, Pen 9 last; Fig. 2).   
Microbiological Testing   
Capture.–Following a ≥ 6 mo acclimation period, we chemically immobilized 
(BAM; 0.43 mg/kg butorpahanol, 0.29 mg/kg, azaperone, 0.17 mg.kg mg/kg 
medetomidine, Wildlife Pharmaceuticals) captive adults via dart rifle (Dan-Inject, 
Børkop, Denmark, EU) at 4-6-week intervals from 1 October – 1 March annually.   
Sampling and testing.–For pathogen detection, we collected duplicate nasal swab 
samples by fully inserting each single polyurethane culture swab (BD CultureSwabTM EZ 
System) sequentially into both nares of each animal, slowly rotating the swab shaft 
against the nasal wall while withdrawing the swab, then replacing the swab in its sheath 
and storing chilled (4C) or frozen (-20C) until received at the laboratory for detection of 
Movi by realtime polymerase chain reaction (Cassirer et al. 2017).  We collected 8-10 ml 
blood via jugular venipuncture and extracted 0.5–1-ml serum for detection of antibodies 
to Movi via competitive enzyme-linked immunosorbent assay (cELISA).  We stored the 
remaining serum at SDSU at -18°C.  All samples were shipped to Dr. Thomas Besser’s 
laboratory at Washington State University (Pullman, WA, USA).  Dr. Besser transferred 
serum samples to the Washington Animal Disease Diagnostic Laboratory (WADDL) for 
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Movi cELISA analyses (Ziegler et al. 2014). We strain-typed all detected Movi by multi-
locus sequence typing as described in Cassirer et al. (2017).   
Carrier class confirmation.–We used cumulative results of serial samples from all 
individuals in our study to confirm adult Movi carrirer classifications.  Due to acute 
infection of adults subsequent indirect transmission, we defined N, I, and S carrier 
individuals as those testing Movi- positive ≤33%, 34-66%, or ≥67% of the time, 
respectively. 
Experiments 
Individuals of known carrier class (N, I, and C) were assigned to pens (Fig. 3) 
based on confirmed Movi strain carriage to determine: (1) the effect of exposure to 
chronic carrier individuals, and (2) lamb survival rates in the presence/absence of ewes of 
different Movi carrier statuses.  Our study was a switch-back design replicated across 
source herds, where adult survival allowed.   
In 2014, we designed 1 treatment pen (≥ 1 C carrier present) consisting of 3 
Asotin ewes, and 2 had lambs.  Alternatively, we had 1 control pen (absent of C carriers) 
of 3 Lostine ewes, and all 3 had lambs.  To review the effect of the exposure of I carrier 
ewes on lamb pneumonia persistence and mortality, we limited 1 control pen to all N 
ewes and 1 control pen to consist of mostly all I ewes from Black Butte using 4 bred 
ewes in each pen.  Comparatively, treatment pens in 2015 consisted of penning N, I, and 
C from the same source herd.  Specifically, we developed pens with N-C, I-C and only C 
ewes from Hells Canyon subpopulations.  Furthermore, we did not have pre-study serial 
samples from Snowstorm ewes, so all ewes and the ram were penned together to develop 
Movi carrier classifications in subsequent years.  In 2016, we derived pen assignments 
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based on recent exposure and Movi carriage using surviving ewes.  We planned control 
pens for both derived populations (Population 1: Strain 404, Population 2: Strain 400) 
using 3 and 4 ewes, respectively.  We had 5 lambs born to the 7 ewes in a control pen in 
2016.  We designed 1 and 3 treatment pens for Population 1 and 2, respectively.  We had 
5 lambs born to the 14 ewes housed in 2016 treatment pens.  Finally, in 2017, we 
designed 1 control pen, with 1 Population 1 ewe birthing 1 lamb.  Comparatively, we 
planned 1 and 3 treatment pens for Population 1 and 2, respectively, in 2017.  We 
assigned N-I-C, N-C, I-C, and only C treatment pens, and 8 lambs were born to the 10 
ewes in the 2017 treatment pens (Fig. 3). 
Lamb Monitoring and Mortality Investigation 
Throughout the course of the study, we conducted daily clinical observations (≥ 
20-min) of each pen to monitor respiratory disease transmission, persistence, and 
recovery of lambs.  Symptoms recorded were: inappetence, lethargy, cough, nasal 
discharge, ear paresis, nose licking, weakness/recumbency, and head shaking.  Symptoms 
observed were scored 0–10, which ranged from not-observed to severe.  Lambs that were 
moribund were euthanized following our IACUC protocol.  All lambs that were 
euthanized or expired naturally in our study were shipped overnight to WADDL for 
complete necropsy, histologic evaluation, bacteriologic culture, and Movi gene analyses 
methods as outlined in Besser et al. (2008).  Following thorough diagnostic investigation, 
cause of death was assumed known with certainty.  We classified mortality causes as one 
of the following: pneumonia, contagious echthyma, gastrointestinal disease, neonatal, 
stillbirth, or abortion. 
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Statistical Analyses 
We used Bayesian hierarchical models to estimate the hazard rates and treatment 
impacts of the presence of at least one Movi chronic carrier on lamb survival.  
Specifically, we used a 2-component model: one that describes lamb age at death, and 
one that describes the cause of death, which is assumed to be known with certainty (Cross 
et al. 2015, Walsh et al. 2018).  We considered cause-specific mortality to be 1 of 2 
possible classes: pneumonia or non-pneumonia related death. 
Each lamb that died during our study contributed the following term (Li) to the 
likelihood: 
Li = Pr (𝑎𝑖 < A < (ai + ∆), Ki = k|A > ai)= hi (ai) exp (- ∫ hi (a) da
ai
0
) × πi,k, 
which was the joint probability of the ith individual’s age at death occurring in the interval 
[ai, ai + ∆] and the cause of death was cause k.  We modeled the age at death by the 
hazard function hi(a), and the probability of dying of cause k was  πi,k. 
Individuals that survived the entire study were right censored and made the 
following contribution to the likelihood: 




To allow for interval-censoring of the age at death, we used the following 
approximation to Li: 
Li = Pr (ei < A < ri, Ki = k|A  > ei)   
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) × πi,k, 
 
where ei was the age the individual entered the study (i.e., 1), ri was the age it was last 
known to be alive, and si was the age it was confirmed dead. The unit cumulative hazard 
rate is represented by the term ψ
a




For various covariate effects on the death hazard rate, we used a log-linear model 
to estimate the proportional hazard effect of covariates using: 
ln (ψ
a,i
) =  βxi + (1 - I15) δa +  I15 (β15xi + δ15,a), 
where β represents the hazard ratio associated with xi, the indicator variable of whether a 
lamb was born in a pen with a chronic carrier(s), δa is a smoothed effect for the a
th age 
interval, I15 was an indicator for the lamb being born during 2015, β15 is the hazard ratio 
associated with xi, an indicator of commingling a lamb with a chronic carrier(s) in 2015, 
and δ15,a was a smoothed effect for the a
th age interval in 2015, which allowed the model 
to account for differences in lamb survival during an unplanned cross-strain transmission 
event in 2015.  Our model was parameterized such that the β15 represented an additive 
effect to β, and the smoothing effects were distinct between 2015 and other years in our 
study. 
We used a logit link function to assess the impact of commingling a lamb with a 
chronic carrier(s) in the probability of a lamb dying from pneumonia: 
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logit (πi,k) = α0 + (α+ζai
) × xi 
where α0 was the effect of dying of pneumonia, α was the treatment effect of 
commingling of lambs with chronic carrier(s), and ζ ai is the spline smoothing effect for 






We used B-spline basis functions as implemented in the splines package in R (R 
Core Team 2018) to create the basis vectors for the ζ ai parameters.  We assumed that 
lambs born in a control pen (absent of ≥ 1chronic carrier(s)) had a constant probability of 
dying from pneumonia.  Combining the various portions of the model produces the full 
likelihood (L) for all N individuals: 




To complete the Bayesian model, we specified a diffuse Normal (0, σ2 = 100) 
prior for each of the β⃗  and 𝛼  parameters.  For the smoothed age effects, we used a 











where δ−a were all ages except a, Μa was the number of neighboring ages for age a, Νa 
was the set of all ages for which j was a neighbor of age a, and τa was the precision term.  
We used a Gamma (1, 1) hyperprior for precision.  We used a unique random walk prior 
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for δ15,a using the same procedure.  Each of the above priors are specified in the BUGS 
language format (Lunn et al. 2000). 
The posterior distribution was then defined as: 
Pr (θ⃗ |data) = L × ∏  [θk]k  
where 𝜃  is the vector of parameters and [θk] was the prior distribution for the kth 
parameter.  
To estimate the posterior distributions of our parameters of interest, we used 
Markov Chain Monte Carlo (MCMC) methods using Nimble in Program R (NIMBLE 
Development Team 2018, R Core Team 2018, Walsh et al. 2018).  We ran 3 chains for 
200,000 repetitions, and removed the first 20,000 iterations for burn-in.  Each chain was 
initialized with dispersed starting values, and we looked for evidence of non-convergence 
by assessing diagnostic plots and calculating the Gelman-Rubin statistic for each 
parameter with the exception of the δa⃗⃗  ⃗ parameters.  If the 95% upper bound of the 
Gelman-Rubin statistic for the parameter was ≤ 1.1, we considered that there was no 
evidence for lack of convergence.   
Posterior predictive checks 
To assess how well our hierarchical model fit these data, we used the quantiles of 
the observed lamb ages at mortality as test statistics.  Using a randomly selected sample 
from the joint posterior distribution of the parameter in combination with individual 
covariates, we stochastically generate an age at death for each individual in the study.  
We then calculated the 10–90% quantiles for these ages and replicated this process 1000 
times.   
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We used the following formula to calculate a sampled Bayesian p-value for the lth 
quantile: 
 P = ∑





where Tl,obs is the observed l
th quantile for age at death, Tl,m is the estimated l
th quantile 
based on the mth replicate, and M is the total number of replicates used.  To jointly assess 
the model’s fit for the overall hazard and cause-specific probabilities, we repeated this 
process but only used the ages of lambs that died of pneumonia, and also calculated the 
probability of dying from pneumonia.  For the latter statistic, we used the above equation 
to calculate the Bayesian p-value, but Tl,obs is the observed probability of a lamb dying of 
pneumonia and Tl,m is the estimated probability based on the m
th replicate. 
RESULTS 
When all mortality causes were pooled across all years of our study, the 
percentage of lamb mortality was more than twice as high when lambs were in born in 
pens containing at least one Movi chronic carrier ewe (treatment), compared to when 
only Movi negative and/or intermittent ewes were present in the pen (control; 92% (n = 
33 of 36) and 38% (n = 5 of 13).  We define years 2014, 2016, and 2017 in our study as 
periods when there was no transmission among pens, and pneumonia mortality was 
limited to lambs (lamb epizootics).  In these years, overall lamb mortality attributed to all 
causes was 70% (n = 16), with 94% (n = 15) of these being lambs born in treatment pens 
(Fig. 3).  Consistent with our hypothesis, no lambs born in control pens developed or died 
of pneumonia in these years of our study (Fig. 3).   
87 
In 2015, presumed aerosolized Movi caused unexpected cross-strain 
transmissions across pens and a subsequent all-age pneumonia epizootic with 88% (n = 
22/25) of all lambs expiring prior to weaning.  Of the 2015 lambs that died, 82% (n = 18) 
were born in a treatment pen with at least one Movi chronic carrier ewe (Fig. 3).  During 
the all-age pneumonia epizootic, all lambs born in a control pen expired prior to weaning, 
but 50% (n = 2) developed and died of pneumonia at 49 and 107 days of age.  The other 
50% (n = 2) developed gastrointestinal disease and died of malnutrition at 20 and 51 days 
of age (Fig. 3), and we failed to detect Movi during diagnostic review of these mortality 
samples.  
Average lamb age at death due to confirmed pneumonia-related mortality was 52 
days (n = 2; range = 42 – 62), 56 days (n = 13; range = 22–107 days), 41 days (n = 4; 
range = 15–79), and 48 days (n = 7; range = 15–113 days) in 2014, 2015, 2016, and 2017, 
respectively.  When pooling lamb mortalities, we recorded more than 8 times as many 
confirmed pneumonia-related lamb mortalities (n = 24; 68%) than any other single cause 
(Fig. 4).  Other causes of bighorn sheep lamb mortality in our models were contagious 
ecthyma (n = 3; 8%; mean age = 91 days; range = 79 – 102), and gastrointestinal diseases 
(e.g., Clostridial disease; n = 3; 8%; mean age = 27 days; range = 9–51).  Neonatal, 
(lambs < 5 days old; n = 3; 8%), dead at birth (n = 3; 8%; Fig. 4) were removed from our 
analysis but still warrant discussion.  Eleven (23%) of 47 total lambs in our study 
survived to weaning.  Four (36%) of the surviving lambs showed clinical signs of 
pneumonia and all were Movi positive at their first conventional health sample (October 
of their birth year).  Two of these surviving lambs were in treatment pens (2015), and two 
were in control pens (2015 and 2016). 
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Overall Mortality Hazard 
The overall log mortality hazard (log hazard hereafter), defined as the rate at 
which lambs expired from any cause prior to weaning in our study, was significantly 
lower during years of expected typical pneumonia epizootics than during the unexpected 
all-age outbreak (Fig. 5).  The mean daily rate at which lambs died of all causes during 
years of typical pneumonia epizootics was slightly above zero and did not significantly 
vary by age.  The estimated posterior distribution presented in our model indicated the 
highest mortality hazard during these years was 87 days of age.  The estimated mean of 
the precision for the smoothed age effects was 3.65 (SD = 1.71, LCI = 1.17, UCI = 7.79; 
Table 2).  In contrast, the overall log mortality hazard during the all-age pneumonia 
epizootic was higher and more variable (Fig. 5).  The mean estimated posterior 
distribution during this year (2015) indicates an age-varying mortality process occurred.  
Our model indicated the log hazard is highest at ages 1–3 days (e.g., neonatal mortality; n 
= 4) with secondary peaks at 38 days of age, which was the median age at death and 100–
108 days of age (Fig. 5).  During 2015, 14% (n = 3) of lambs that died prior to weaning 
exceeded 100 days of age.  The estimated mean of the precision for the smoothed age 
effects was 2.15 (SD = 1.19, LCI = 0.59, UCI = 5.14; Table 2).          
Our model estimated commingling increased the log hazard during lamb epizootic 
pneumonia (i.e., non-2015 years).  The rate of lamb mortality occurred significantly 
faster when a lamb was born in a treatment pen (mean log hazard = 2.80; SD = 0.78, UCI 
= 1.37, LCI = 4.40; Table 2).   
During the all-age pneumonia epizootic in 2015, there was a negative effect on 
the estimated log hazard if a lamb was born in a treatment pen with at least one chronic 
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Movi carrier adult (mean log hazard = -2.36, SD = 0.90, LCI = -4.16, UCI = -0.62; Table 
2).  We documented 4 lambs infected with a Movi strain type that differed from those 
carried by ewes prior to 2015 lambing.  However, the 2 control lambs expired from a 
strain previous carried by their dams in the wild.  Further, 1 lamb born in a treatment pen 
that year and survived carried a novel strain type at the first sample post-weaning 
(October 2015).  
Conditional Probability of Pneumonia 
Confirmed pneumonia-induced lamb mortality was recorded as the cause of 85% 
(n = 22) over 3 years and 59% (n = 13) of all lamb deaths during expected typical 
pneumonia epizootics and an all-age pneumonia epizootic (1 year), respectively.  The 
mean posterior parameter estimate for the probability that individual’s death was due to 
pneumonia on the logit scale was -1.01 (SD = 0.80, LCI = -2.74, UCI = 0.45; Table 2).  
Given a lamb died, our model estimated the probability of dying of pneumonia was 
highest at lamb ages 16–61 and ≥ 98 days of age (Fig. 6).  The mean of the precision for 
the spline smoothing effect on the conditional probability of pneumonia mortality was 
0.15 (SD = 0.27, LCI = 0.01, UCI = 0.80; Table 2).   
Our model estimated the probability the cause-of-death was pneumonia was 
higher for lambs born in a treatment pen with a Movi chronic carrier compared to those 
that were born in a control pen without a Movi chronic carrier (mean = 3.50, SD = 1.30, 
LCI = 1.28, UCI = 6.39; Table 2).  The mean probability of pneumonia-induced mortality 
for lambs born in a treatment pen was above 0.75 by 15 days of age and generally 
remained above that level for the duration of the study.  Our model also estimated this 
probability to be elevated (≥ 0.90) as early as 16 days of age until 45 days of age, and a 
90 
secondary peak for older, nearly weaned, lambs (105–114 days of age). Confirmed 
pneumonia-specific mortality was not likely for lambs less than 14 days of age (Fig. 7).   
Pneumonia Hazard 
The effect of commingling lambs with at least one Movi chronic carrier had a 
substantial influence on the age-varying pneumonia hazard of captive bighorn sheep 
lambs in years without an all-age epizootic (Fig. 8). Pneumonia-induced mortality hazard 
was significantly lower for lambs not directly exposed to a chronic carrier.  Age-varying 
mean pneumonia mortality hazard for lambs that were born in a control pen was low but 
peaked at approximately 0.001 around 90 days of age.  In contrast, when born in a 
treatment pen with a chronic carrier ewe, lamb pneumonia hazard increased at least 2-
fold by 15 days of age and remained higher than the hazard of the lambs born in a control 
pen for all subsequent ages during our study (Fig. 8).   
Posterior Predictive Checks 
Although it appears that the model estimated ages of death may be slightly lower 
than those observed, all Bayesian p-values derived for age at death for 10–90% quantiles 
fall within the interval [0.05, 0.95], which demonstrated no evidence for significant lack 
of fit (Table 3).  Similarly, the p-values for 10–90% quantiles for age at death for lambs 
dying of pneumonia did not indicate a lack of fit (Table 3), nor did the test statistic for the 
probability of a lamb dying of pneumonia, which had a p-value = 0.079. 
DISCUSSION  
To date, this is the first formal longitudinal captive experiment using a priori 
intensively sampled known individuals from multiple free-ranging populations aimed to 
identify Movi carrier class, persistence and associated impacts on lamb survival.  
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Consistent with our hypothesis, a high proportion of lambs experienced fatal pneumonia 
when born in a pen with at least 1 chronic carrier.  Simultaneously, lambs failed to 
develop respiratory disease altogether or cleared infection and remained healthy in the 
absence of chronically infected adults.  The proportion of lambs that died during our 
study, regardless of confirmed cause, was more than twice as high when born into a 
treatment pen and was directly exposed to at least one Movi chronic carrier than when 
born in a control pen and exposure was limited to negative and/or intermittent Movi 
carriers.   
Our study provides additional support for the premise that chronic Movi carriers 
serve as the source of pathogen transmission that initiates fatal pneumonia outbreaks in 
lambs in free-ranging populations.  If even a small proportion of ewes are chronic 
carriers, pathogen transmission occurring by dam-lamb interaction is then amplified by 
transmission within lamb nursery social contact networks.  Preliminary findings from a 
parallel captive study at Washington State University reported all (n = 2) lambs born in a 
pen with a single chronic Movi carrier developed and died from pneumonia; whereas, all 
(n = 4) lambs born in a pen with Movi-negative ewes remained non-pneumonic and 
survived (Weyand et al. 2018).  A metapopulation of free-ranging bighorn sheep in Hells 
Canyon experienced a higher proportion of lamb mortality for lambs born to chronically 
infected ewes as compared to negative and/or intermittently infected ewes (Plowright et 
al. 2017).  Further, Garwood et al. (2020) failed to detect Movi and associated 
pneumonia-induced lamb mortality following the removal of chronic carriers from a free-
ranging population in South Dakota.   
92 
Only 6% (n = 2) of lambs born in a pen with a chronic Movi carrier ewe survived 
in our study.  One of these lambs displayed severe signs of respiratory disease, was 
generally lethargic and exhibited stunted growth; whereas, the other lamb presented mild 
indications of clinical respiratory disease but otherwise appeared healthy.  Both of these 
surviving lambs were subsequently Movi positive in serial samples, meeting the 
definition of a chronic Movi carrier, but eventually succumbed to pneumonia by 2 years 
of age.  It is plausible that lambs that survive neonatal Movi infection and are unable to 
clear the infection are an important source of chronic Movi carriers for wild populations, 
hindering bighorn sheep recovery. 
Other studies document low survival of offspring when exposed to Movi (Smith 
et al. 2014, Plowright et al. 2017, Garwood et al. 2020).  Movi-positive bighorn sheep 
herds in South Dakota documented 2% and 11% lamb survival to recruitment (Smith et 
al. 2014, Garwood et al. 2020).  Our study supported many reports of peak pneumonia-
induced lamb mortality occurring between 30 and 100 days of age (Ryder et al. 1992, 
Enk et al. 2001, Smith et al. 2014, Garwood et al. 2020).  Our study supports Wood et al. 
(2017) in documenting the pneumonia-induced mortality in younger captive lambs (≤ 15 
days of age; n = 2).  The younger lamb fatal cases in our study had limited or no clinical 
disease but experienced abrupt lethargy and subsequent rapid morality as noted by Wood 
et al. (2017).  Alternatively, fatal cases in lambs 16–65 days of age (n =16) caused by 
pneumonia experienced disease characterized by coughing, nasal discharge, and/or ear 
paresis first evident by approximately 14 days of age and rapidly progressing until 
mortality; whereas, older-aged pneumonia-caused fatal cases (≥ 65 days of age; n = 6) 
had a prolonged disease course that was generally characterized by a delayed (≥35 days) 
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onset of clinical symptoms, even if born in a pen with a Movi chronic carrier.  For older-
aged lambs that died of pneumonia, the disease course and subsequent progression of 
coughing, nasal discharge, and/or ear paresis was gradual until mortality. The variability 
of disease progression in juveniles may partially explain some of the dynamics of this 
devastating disease reported in free-ranging populations. The period of disease in which 
symptoms were not apparent for older lambs may have implications for disease detection 
because they may appear healthy for several weeks or months following parturition.   
Recent research and management observations reveal Movi strains (genotypes) 
vary in pathogenicity (Felts et al. 2016, Justice-Allen et al. 2016, Cassirer et al. 2017).  
Of the younger-aged pneumonia confirmed mortalities, 100% (n = 2) were the result of 
infection with the NV-400 Movi strain, which was initially carried by the Snowstorm 
(Nevada) sheep in our study.  Comparatively, 83% (n = 5) of the older-aged pneumonia-
caused fatal cases documented in our study were caused by the HC-404 Movi strain 
initially carried by the Hells Canyon (Idaho, Washington, Oregon) bighorn sheep (Table 
1).  Furthermore, all (n = 6) lambs that survived the presence of an adult Movi chronic 
carrier for >100 days of age carried the HC-404 Movi strain.  Although anecdotal, this 
suggests that Movi strains in our study may vary in virulence or that some maternal 
immunity may have increased protection, in some cases.  Another explanation for these 
young-aged pneumonia-induced mortalities may be the result of pathogenic secondary 
infections (e.g., Mannheimia haemolytica) following Movi colonization.  Although cross-
strain transmissions occur in free-ranging populations (Justice-Allen et al. 2016, Cassirer 
et al. 2017), it is unlikely that any wild bighorn sheep population will face multiple 
simultaneous strain challenges as presented in our study (Table 1; Fig. 2a).   
94 
Alternatively, strain type virulence may not explain the anecdotal observations of 
abrupt mortality and prolonged survival of lambs infected with the NV-400 and HC-404 
strains, respectively. The clinical stage of infection of the infectious individual(s) 
carrying these two strains and transmitting them to the lambs may explain, or work in 
concert with strain virulence, to drive observed disease dynamics.  Acutely infected (e.g., 
symptomatic) adults would present lambs with a higher pathogen load compared to 
asymptomatic chronic carriers.  Disparity exists between acute and chronic shedding rates 
(Pathak et al. 2010).  Due to the acute infection attributed to indirect cross-pen 
transmission during 2015, animals that were not chronic carriers became infected.  
However, subsequently, when the chronic carriers were separated out, most non-carriers 
cleared infection and remained healthy. 
Movi is highly transmissible, and direct contact is not required for epizootic 
spread of pneumonia in captive bighorn sheep studies (Besser et al. 2014; Felts et al. 
2016).  During an all-age pneumonia epidemic, a control pen (Pen 1) with adults and 
lambs penned together were indirectly exposed to Movi, or the adults were indirectly 
exposed then directly exposed lambs.  Lambs born control pens only succumbed to fatal 
pneumonia when our study experienced an unintentional all-age fatal pneumonia 
epizootic in 2015.  During this period, negative ewes become indirectly and acutely 
infected with a novel Movi strain (Appendix A; Felts et al. 2016).  Laboratory analyses of 
Movi and subsequent strain typing of conventional health and environmental samples 
allowed us to confirm cross-strain transmissions, which we attributed to infectious 
aerosols generated by coughing infected animals in other pens.  During this period in our 
study, 2 lambs born in Pen 1 (control) succumbed to gastrointestinal disease by July 20, 
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2015.  Neither lamb presented indication of pneumonia during daily observations or 
necropsy, and both were Movi-negative by PCR and seronegative at the time of their 
death (Table 4).  The remaining 2 lambs born in Pen 1 developed and succumbed to 
pneumonia by September 5, 2015.  Pneumonic lambs exhibited severe indications of 
respiratory disease during daily observations and severe lesions at necropsy and were 
Movi-positive by PCR and seropositive upon laboratory evaluation of mortality samples 
(Table 4).  Therefore, we surmise the individuals in the control pen (Pen 1) were 
indirectly infected after birth with aerosolized Movi following the non-pneumonic lamb 
mortalities in that pen by July 20, 2015. 
Our study corroborates Garwood et al. (2020)’s anecdotal interpretation in which 
some cases of intermittent carriage can be attributed to cross-strain transmissions.  The 
contribution of intermittent carriers to pathogen persistence remains unknown.  Review 
of the stability of Movi carrier classifications was not possible due to the severe outbreak 
that occurred in 2015 and further concerns of aerosol transmission.  The degree of carrier 
classification consistency remains unclear and warrants careful study.  If these 
classifications fluctuate (i.e., intermittent carriers become chronic carriers), targeted culls 
of intermittent carriers may also be necessary for bighorn sheep recovery. 
MANAGEMENT IMPLICATIONS 
Our study underscores the importance of chronic Movi carriers in the long-term 
persistence of pneumonia and associated depression of lamb survival, which are the 
principal threats to bighorn sheep recovery.  A high proportion (92%) of all lambs did not 
survive when born in a pen with a chronic Movi carrier ewe.  Both direct and indirect 
transmission may present managers with cases of prolonged clinical disease progression 
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and low lamb recruitment.  Our study also demonstrates that targeted individual adult 
hosts can disproportionately affect populations.  Therefore, it is critical to longitudinally 
sample individuals to identify those that are critical in driving disease dynamics.  A free-
ranging population that harbors even a small proportion of adult chronic Movi carriers 
may present wildlife managers with a stagnant or declining bighorn sheep population due 
to limited-to-no annual lamb recruitment.  Management should continue to prioritize 
resources that target and remove chronic Movi carriers and prevent spillover of novel 
Movi strains, which cause all-age pneumonia outbreaks.  
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Table 1. South Dakota State University captive bighorn sheep source herds, Mycoplasma 
ovipneumoniae genotypes (strain) defined in our study includes source herd identification 
(HC: Hells Canyon; BB: Black Butte; SD: South Dakota; NV: Nevada), and number of 
adult bighorn sheep used in our study. 
 
Source Herd Movi Strain  n 
Hells Canyon   
      Asotin HC-404 7 
      Lostine HC-404 5 
      Sheep Mountain HC-404 2 
      Black Butte BB-393 8 
South Dakota   
      Rapid Creek SD-398 1 
      Badlands SD-398 2 
Nevada   
      Snowstorm NV-400 14 
   




Table 2. Posterior parameter estimates including the mean, standard deviation (SD), 95% 
lower credible limit (LCL), and 95% upper credible limit (UCL).  Parameter estimates 
presented below include an effect in which lambs were born in a pen with at least 1 
Mycoplasma ovipneumoniae (Movi) chronic carrier (treatment), an all-age pneumonia 
outbreak that occurred across pens during presumed acute disease of ewes (2015), and 
Movi-induced fatal pneumonia for bighorn sheep lambs. 
 Parameter estimate Mean SD LCL UCL 
Treatment effect-log hazard  2.80 0.78 1.37 4.40 
    Precision-age log hazard  3.65 1.71 1.17 7.79 
Treatment effect 2015-log hazard  -2.36 0.90 -4.16 -0.62 
    Precision-age log hazard 2015  2.15 1.19 0.59 5.14 
Probability of pneumonia-logit -1.01 0.80 -2.74 0.45 
    Precision-probability of pneumonia-logit 0.15 0.27 0.01 0.80 
Pneumonia-logit treatment 3.50 1.30 1.28 6.39 
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Table 3. Bayesian p-values derived from posterior predictive checks, which assess how well the hierarchical models for lamb 
ages at mortality fits these data.  Quantiles of 10–90% are presented and for the interval (0.05, 0.95).   
Predictive parameter  10% 20% 30% 40% 50% 60% 70% 80% 90% 
Age at death 0.625 0.668 0.801 0.824 0.946 0.886 0.834 0.773 0.136 
Age at death for 
pneumonia mortality 0.414 0.421 0.464 0.463 0.543 0.676 0.371 0.282 0.127 








Table 4. Cause of mortality for lambs born in a control pen (no Movi chronic carrier present).  Movi PCR cycle results ≤ 36.0, 
36.1–39.9, and 40 indicate a positive, indeterminate, and negative sample, respectively.  Movi ELISA ≤ 50% inhibition 
represents a seropositive test.  Movi ELISA test results of “NA” indicates analysis was not conducted for that individual.  
Year Population Pen              
Ewe  







2015 3 1 Negative gastrointestinal disease 20 11 July 40 67.789 
2015 3 1 Negative gastrointestinal disease 51 20 July 40 -14.219 
2015 3 1 Negative pneumonia 49 24 July 17.22 NA 
2015 3 1 Negative pneumonia 109 5 September 18.54 86.391 
2016 1 393 Negative contagious ecthyma 91 19 August 40 NA 




Figure 1. Wild bighorn sheep source herds selected for translocation to the South Dakota 
State University Captive Wildlife Research Facility, Brookings, South Dakota. 
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Figure 2. Captive bighorn sheep research facility design and pen assignments based on known-Mycoplasma ovipneumoniae 
(Movi) history and confirmed prior to parturition in 2014–2017.  Longitudinal Movi strain types were the basis of pen 
assignments and are presented.  Movi carriage by PCR is presented as positive ((+)) or negative ((-)).  Adult bighorn sheep sex 














Figure 3. Experimental commingling pen assignments of bighorn sheep ewes by Mycoplasma ovipneumoniae (Movi) strain 
types and carrier classifications: Negative (N), Intermittent (I), or Chronic (C). Twenty-four lambs were born in 14 pens during 
a chronic carrier experiment (2014, 2016, and 2017) and 25 lambs were born in 6 pens in 2015 the year of a pneumonia 
outbreak that occurred when Movi was transmitted across pens.  Lamb fate is represented as survived to weaning (open circle), 
pneumonia mortality (black circle), or non-pneumonia mortality (grey circle).  Cause-specific mortality was confirmed at 
necropsy.  Treatment (lambs were born in a pen with at least one Movi chronic carrier) pen assignments are denoted by the 
pink solid bordered area; whereas, control assignments (lambs were born in a pen without at least one Movi chronic carrier) 
are the blue dashed images. 
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*indicates ewes experienced a novel infection and were acutely infected with Movi strain 404 (Population 1 in subsequent 
years of the study) 
** indicates ewes experienced a novel infection and were acutely infected with Movi strain 400 (Population 2 in subsequent 
years of the study)
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Figure 4. Cause-specific mortality of 39 captive bighorn sheep lambs from 2014–2017.  We followed necropsy protocols on 
fresh cadavers to investigate and confirm all sources of mortality.  Gastrointestinal diseases included necrotizing colitis and 





Figure 5. Age-varying overall log hazard rate of 39 bighorn sheep lamb mortalities due to 
any cause during lamb epizootic pneumonia with the absence of Mycoplasma 
ovipneumoniae transmissions among pens (non-2015 years of the study) and during an 
all-age pneumonia epizootic across pens (2015) at the South Dakota State University 
captive bighorn sheep facility.  Lamb age is presented as days after birth, and shaded 





Figure 6. Age effect for the logit probability of mortality attributed to pneumonia for 24 














Figure 7. Age-varying probability of pneumonia-related mortality when bighorn sheep 














Figure 8. Age-varying log hazard rate of mortality attributed to pneumonia for bighorn 
sheep lambs born in a treatment pen with at least one Mycoplasma ovipneumoniae 
chronic carrier present or control pen without a Mycoplasma ovipneumoniae chronic 








APPENDIX A. Pre-study Data, Carrier Classification, and Additional Serial Samples 
Monitoring efforts for Mycoplasma ovipneumoniae (Movi) were conducted by state wildlife agencies prior to 
translocation to South Dakota State University (SDSU).  Individual sampling events with source herds listed as “-SDSU” 
indicate the sampling event for capture of that individual, translocation, and entering our captive study at SDSU.  Adult 
bighorn sheep sex is indicated as “F” (female) or “M” (male).  Estimated ages for individuals and sample dates are described.  
We removed state’s serial samples collected ≤ 3 months from previous sample to minimize biasing Movi classification of 
individuals for our study.  The evaluation of Movi exposure for free-ranging populations by wildlife managers is common, and 
ELISA percent inhibition > 50% indicates detection for that sampling event.  Finally, individual Movi detection in serial 
samples prior to the study are presented.   
For Movi classification of the 40 adult bighorn sheep in our captive study, we reviewed Movi PCR results prior to the 
study and classified individuals as a Negative, Intermittent, or Chronic Movi carrier.  Classifications were based on that 
individual testing positive for Movi < 0%, 1–74%, or ≥ 75% of the time prior to the lambing period of the individual’s entry 
year into the study, respectively.  For Movi classification purposes, we considered indeterminate Movi PCR results as 
detections and are indicated as “I-Yes” because it was unknown what PCR cycle threshold was considered a detection (i.e., 
34th cycle or 36th) at that sampling event.  Pen assignments were based on Movi classifications and population (“Pop.”) number 
(Fig. 3).   
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We also offer sample results for individuals following the lambing period of their entry year to confirm Movi carriers 
and assess potential exposure to lambs.  We also describe serial samples for some Negative classified Movi carriers during an 
acute infection which occurred during an all-age pneumonia epidemic in 2015.   For these individuals, an * indicates that all 
remaining serial samples (2015–2017) failed to detect Movi.  Finally, serial samples for rams (M) are described. 
 























Mildred Lostine F 14.6 12/31/12 87.09 Yes            
Mildred Lostine F 14.7 1/31/13 82.40 Yes       
Mildred Lostine-SDSU F 15.8 2/26/14 74.84 Yes  100 Chronic 7 1 2014 
Mildred SDSU F 16.5 10/30/14 50.73 Yes       
Elsie Lostine F 11.7 1/31/13 91.08 Yes            
Elsie Lostine F 12.7 1/14/14 86.78 Yes       
Elsie Lostine-SDSU F 12.8 2/25/14 73.92 I-Yes  100 Chronic 7 1 2014 
Elsie SDSU F 13.5 10/30/14 76.96 I       
Ronda Lostine F 4.6 12/13/12 86.98 Yes            
Ronda Lostine F 4.8 3/1/13 80.90 Yes       
Ronda Lostine-SDSU F 5.8 2/26/14 69.87 No  67 Intermittent 7 1 2014 
Ronda SDSU F 6.5 10/30/14 61.57 No       
Nora Asotin F 4.4 10/4/12 57.20 No            
Nora Asotin F 5.5 11/26/13 63.92 No       
Nora Asotin-SDSU F 5.8 2/26/14 67.63 No  0 Negative 1 1 2014 
Nora SDSU F 6.5 10/30/14 6.08 No       
Ruby Asotin F 4.6 12/19/13 72.54 No            
122 
Ruby Asotin-SDSU F 4.6 2/26/14 82.70 No  0 Negative 1 1 2014 
Ruby SDSU F 5.8 3/19/14 70.88 No       
None Asotin F 6.4 10/4/12 65.66 No            
None Asotin-SDSU F 7.8 2/26/14 84.16 No  0 Negative 1 1 2014 
None SDSU F 8.5 10/30/14 NA No       
             
Mamie Lostine F 12.6 12/13/12 90.49 No            
Mamie Lostine F 12.7 2/6/13 91.08 No       
Mamie Lostine F 13.7 1/15/14 80.34 No       
Mamie Lostine-SDSU F 14.7 1/13/15 69.19 Yes  25 Intermittent 3 1 2015 
Mamie SDSU F 14.9 10/5/15 45.99 Yes       
Crash Asotin F 10.6 12/30/13 81.31 No            
Crash Asotin F 10.8 2/26/14 86.81 Yes       
Crash Asotin F 11.5 11/12/14 75.60 I-Yes       
Crash Asotin-SDSU F 11.7 1/14/15 70.86 Yes  75 Chronic 3 1 2015 
Crash SDSU F 11.9 3/19/15 58.71 I       
Abby Lostine F 12.8 3/7/13 89.61 Yes            
Abby Lostine F 13.7 1/15/14 88.15 Yes       
Abby Lostine-SDSU F 14.7 1/13/15 70.44 Yes  100 Chronic 8 1 2015 
Abby SDSU F 14.8 11/9/15 87.93 Yes       
Boots Asotin F 4.8 2/26/14 91.19 I-Yes            
Boots Asotin-SDSU F 5.7 1/14/15 42.83 Yes  100 Chronic 8 1 2015 
Boots SDSU F 5.7 11/9/15 83.75 Yes       
Calamity 
Sheep Mtn-
SDSU F 18.7 2/5/15 52.70 Yes 
 
100 Chronic 8 1 2015 
Calamity SDSU F 18.9 3/18/15 58.43 Yes       
Calamity SDSU F  10/30/15 76.55 Yes       
Annie 
Sheep Mtn-
SDSU F 10.7 2/5/15 72.55 Yes 
 
100 Chronic  8 1 2015 
Annie SDSU F 10.8 3/18/15 77.51 I       
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Annie SDSU F   10/30/15 82.59 Yes       
Dolly Black Butte F 3.5 11/30/11 3.23 No            
Dolly Black Butte F 5.8 2/27/14 82.28 No       
Dolly 
Black Butte-
SDSU F 6.4 10/8/14 83.85 No 
 
0 Negative 1 3 2015 
Dolly SDSU F 6.8 2/20/15 83.32 No       
Dolly SDSU F 6.8 3/18/15 77.05 No       
Dolly SDSU F   9/8/15 84.97 Yes       
Dolly SDSU F  11/25/15 83.75 No*       
Amelia Black Butte F 4.8 2/27/14 65.34 No            
Amelia 
Black Butte-
SDSU F 5.4 10/8/14 78.18 No 
 
0 Negative 1 3 2015 
Amelia SDSU F 6.8 2/20/15 88.10 No       
Amelia SDSU F 6.8 3/18/15 81.75 No       
Amelia SDSU F   9/8/15 84.97 Yes       
Amelia SDSU F   12/7/15 82.07 No*       
Diva Black Butte F 4.8 2/27/14 42.77 No            
Diva 
Black Butte-
SDSU F 5.4 10/8/14 79.68 No 
 
0 Negative 1 3 2015 
Diva SDSU F 6.8 2/12/15 63.61 No       
Diva SDSU F 6.8 3/18/15 51.06 No       
Diva SDSU F   9/8/15 79.40 Yes       
Diva SDSU F  11/24/15 71.16 No       
Diane Black Butte F 11.8 2/27/14 63.05 No            
Diane 
Black Butte-
SDSU F 12.4 10/8/14 82.25 No 
 
0 Negative 1 3 2015 
Diane SDSU F 12.8 2/10/15 82.44 No       
Diane SDSU F 12.8 3/18/15 80.46 No       




SDSU F 5.4 10/8/14 80.86 No 
 
50 Intermittent 5 3 2015 
Patsy SDSU F 6.8 2/21/15 NA No       
Patsy SDSU F   10/6/15 75.30 No       
Patsy SDSU F  10/27/15 NA Yes       
Loretta 
Black Butte -
SDSU F 6.4 10/8/14 87.49 Yes 
 
          
Loretta SDSU F 6.8 2/21/15 87.61 No   Intermittent 5 3 2015 
Loretta SDSU F   10/6/15 82.11 No       
Loretta SDSU F   10/27/15 82.99 Yes       
Tammy Black Butte F 5.1 7/3/14 89.92 Yes            
Tammy 
Black Butte-
SDSU F 5.4 10/8/14 86.10 No 
 
50 Intermittent 5 3 2015 
Tammy SDSU F 7.8 2/20/15 81.56 No       
Norma Black Butte F 10.8 2/27/14 45.12 No            
Norma 
Black Butte-
SDSU F 11.4 10/8/14 80.64 No 
 
0 Negative 5 3 2015 
Norma SDSU F 11.8 2/20/15 88.19 No       
Norma SDSU F 12 5/20/15 NA No       




     
Athena  
Snowstorms-




    9 2 2015 
Athena SDSU F 6.8 3/18/15 57.97 Yes            
Bean  
Snowstorms-




    9 2 2015 
Bean SDSU F   7/15/15 63.84 Yes            
Dixie Snowstorms F   11/5/12 57.58 Yes      9     
Dixie 
Snowstorms-




100 Chronic  2 2015 








    9 2 2015 
Lady SDSU F   7/30/15 79.98 Yes            
Lolita  
Snowstorms-




    9 2 2015 
Lolita SDSU F  7/30/15 66.05 Yes       
Pearl  
Snowstorms-




    9 2 2015 
Pearl SDSU F   7/16/15 83.86 Yes            
Penny  
Snowstorms-




    9 2 2015 
Penny SDSU F 4.8 3/18/15 57.88 Yes            
Reba  
Snowstorms-




    9 2 2015 
Reba SDSU F 1.8 3/18/15 34.38 No       
Tizzy Snowstorms F   8/30/11 55.52 Yes      9 2 2015 
Tizzy  
Snowstorms-




     
Tizzy SDSU F  7/16/15 74.20 No       
X-Factor  
Snowstorms-




    9 2 2015 




SDSU M  3.6  
12/9/14  67.90  I-Yes  
 
    9 2 2015 
Aldo SDSU M  7/15/15 70.75 Yes       
                         
Pink Snowstorms  F   12/1/15 63.91 Yes            
Pink  
Snowstorms-
SDSU F 9.7 2/1/17  I-Yes 
 
100 Chronic 11 2 2016 
Pink SDSU             




SDSU F 8.7 2/1/17  I-Yes 
 
100 Chronic 11 2 2016 
Olive SDSU             
Nana Snowstorms  F 2.7 12/1/15 44.85 Yes           
Nana  
Snowstorms-
SDSU F 2.7 2/1/17  Yes 
 
100 Chronic 11 2 2016 
Nana SDSU             
Diablo Snowstorms  F 6.7 12/9/14 82.80 No           
Diablo  
Snowstorms-
SDSU F 6.7 2/1/17  I-Yes 
 
100 Chronic 11 2 2016 
Diablo SDSU             
                         
Jax SDSU M  10/30/14 50.81 No      2014 
Axel SDSU M  10/30/14 86.21 No      2014 
Stevie SDSU M 0.8 2/28/14 83.84 Yes      2014 
Stevie SDSU M 2 5/27/15 62.93 No       
Asotin Asotin M 0.8 2/26/14 79.62 Yes      2015 
Asotin Asotin-SDSU M 1.5 11/11/14 28.97 No       
Asotin SDSU M 2 5/20/15 60.44 No       
Dillinger Asotin-SDSU M 2.5 11/11/14 -2.99 No      2015 
Dillinger SDSU M 2.7 2/5/15 4.68 No       
Dillinger SDSU M 3 5/20/15 9.90 No       
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CHAPTER 3: UNILATERAL AND BILATERAL RESPIRATORY DISEASE 






This chapter is being prepared for publication and was coauthored by Thomas E. Besser, 




Infectious respiratory disease has long been identified as the cause historical 
declines and extirpations of bighorn sheep (Ovis candensis), and Mycoplasma 
ovipneumoniae (Movi) is the primary pathogen inducing disease and mortality.  Sampling 
for Movi often entails collecting multiple nasal swabs, but sampling and handling 
protocols may vary.  Comparison of Movi detection rates associated with protocols that 
conduct unilateral or bilateral sampling of the nares and/or collect multiple swabs has not 
been described.  Therefore, the primary objective of this study was to inform field 
sampling techniques for reliable disease surveillance of bighorn sheep populations by 
conducting these evaluations.  We selected captive adult bighorn sheep with known Movi 
carrier histories to describe the probability of Movi detection using unilateral and 
bilateral sampling of the nares and the effects of taking multiple samples.  The overall 
Movi mean detection probability for bilateral upper respiratory samples was 0.18 higher 
(95% CI = 0.10–0.26) than unilateral samples.  Movi detection probability decreased as 
consecutive multiple samples were taken, particularly for unilateral samples, but was not 
statistically significant.  We documented complete or near unilateral Movi colonization in 
27% (n = 3) of the bighorn sheep used in our study, which to our knowledge, is the first 
study to document this.  Wildlife managers should ensure sampling protocols explicitly 
require bilateral nasal swabs for Movi PCR analyses.   Although the first sample taken 
appears to have the highest Movi detection probability, multiple samples may be taken.  
There may be a reduction of detection probability from samples collected later in the 
sampling process, however, so managers who need to collect multiple nasal samples for 
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various management or research needs should prioritize samples for analysis reflective of 
the order in which they were collected. 
INTRODUCTION 
Wildlife disease investigations require reliable field sampling techniques and 
subsequent laboratory evaluations of infectious pathogens.  Wildlife managers use the 
results of accepted diagnostic assessments to make inferences for disease management 
actions.  However, successful disease surveillance may be vulnerable to imperfect 
diagnostic tests (i.e., detection probability <1).  A non-detection may arise from the target 
pathogen truly not being present during the investigation or may result from the pathogen 
being present but not being detected (i.e., false negative; McClintock et al. 2010, Walsh 
et al. 2012).  A false negative for targeted infectious pathogens may have severe 
implications for wildlife disease control measures.  Further, wildlife disease surveillance 
can be inherently challenging due to logistical and financial constraints, particularly when 
retesting free-ranging individuals (Garwood et al. 2020).  Therefore, it is imperative to 
understand the impacts of survey protocols on the performance of diagnostic tests by 
conducting carefully controlled scientific investigations to determine the most efficient 
and effective protocol for pathogen detection (Stallknecht 2007, Ryser-Degiorgis 2013, 
Walsh et al. 2016). 
Infectious respiratory disease has long been identified as the cause of bighorn 
sheep historical declines and extirpations (Shillinger 1937, Cassirer et al. 2018).  Bighorn 
sheep respiratory disease typically manifests as prolonged periods of disease, often with 
high juvenile and sporadic adult mortality (Manlove et al. 2014, Smith et al. 2015).  
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Infectious respiratory disease is the primary impediment for bighorn sheep recovery 
(Besser et al. 2012, Cassirer et al. 2018).   
Historically, investigators have grappled to explain etiological agents causing 
fatal polymicrobial respiratory disease in bighorn sheep.  Advances in culture-
independent diagnostics (i.e., polymerase chain reaction, PCR) allowed investigators to 
identify the primary pathogen affecting bighorn sheep.  Using PCR assessments, Besser 
et al. (2008) described Mycoplasma ovipneumoniae (Movi) as the first pathogen to 
invade the lower respiratory tract.  Failure of mucociliary clearance caused by Movi in 
the upper respiratory tract predisposes infected animals to secondary pathogens (Besser et 
al. 2008, Besser et al. 2012, Besser et al. 2013).  A growing body of experimental and 
empirical data support that Movi is the primary pathogen causing infectious respiratory 
disease in bighorn sheep (Cassirer et al. 2018).  For this reason, our study focuses on this 
agent. 
The incidence of imperfect detection of infectious pathogens in wildlife studies 
has been reviewed for a variety of taxa (McClintock et al. 2010, Lachish, et al. 2012) 
including recent investigations summarizing variation in detection probability of 
infectious pathogens affecting bighorn sheep (Ovis canadensis; Walsh et al. 2012, Walsh 
et al. 2016, Butler et al. 2017).  Swabbing the nasal cavities is the preferred sampling 
methods for Movi detection (Fox et al. 2015, Butler 2017).  Imperfect detection and the 
power to detect pathogens affecting bighorn sheep may occur due to variation in disease 
sampling protocols and in the handling of nasal swabs (Butler et al. 2017).  Bighorn 
sheep respiratory disease sampling protocols typically call for collecting bilateral nasal 
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samples (Drew et al. 2014), but Movi detection rates and probability for unilateral and 
bilateral samples have not been reported. 
Further, due to logistical constraints on resampling wild animals, multiple 
samples are frequently collected to provide data for multiple research efforts, temporally 
monitor disease status for individuals and populations, establish and develop sample 
banks, and to inform management decisions.  Under normal sampling protocols, 
investigators typically collect 1 to 4 bilateral nasal swabs per individual (Drew et al. 
2014, Butler et al. 2017).  To our knowledge, however, potential variation for detection 
probability associated with collecting multiple nasal samples and possible PCR signal 
decay or exhaustion in serial samples for Movi have yet to be reported.  Further, research 
indicates intranasal deposition of various size particles during respiration exist in 
different location within the nasal cavity (Keck et al. 2000, 2001).  This has not been 
investigated for Movi in bighorn sheep. 
We selected captive adult bighorn sheep with known Movi carrier histories to 
describe the probability of detection of this pathogen under various common sampling 
protocols.  Specifically, we review the potential effects of Movi detection probability 
based on presumed pathogen signal decay associated with collection of multiple swabs 
from an individual animal, anatomical location of pathogens (anterior vs posterior), and 
differential pathogen colonization of nares.  The primary objective of this study is to 
inform field sampling techniques to ensure efficient and rigorous disease surveillance of 




The study was conducted at the South Dakota State University (SDSU) Captive 
Wildlife Research Facility in Brookings, South Dakota (44°20´ N, 96°47´ W) on 11 adult 
bighorn sheep transported from free-ranging populations in Washington (n = 6; Asotin 
herd n = 5, Black Butte herd n = 1), Oregon (n = 3; Lostine herd), and Nevada (n = 2; 
Snowstorm herd; Fig. 1).   
Temperature at the study site ranges from -29°C–38°C with a mean annual 
temperature of 8°C (Spuhler et al. 1971).  Mean regional precipitation ranges from 33–
63.5 cm, including snowfall of 63.5–114 cm (Spuhler et al. 1971).  The prevailing wind 
direction is from the south in the spring and the north-northwest during the winter.  Wind 
speeds can exceed 80.5 km/h; however, the average annual wind speed in the region is 
17.7 km/h (Spuhler et al. 1971). 
Captive animals were provided fresh alfalfa-grass mixed hay, pelleted soybean 
hulls, water, and loose mineral ad libitum daily.  Capture, transport, daily care and animal 
sampling protocols were reviewed and approved by the SDSU Institutional Animal Care 
and Use Committee (Number 14-076A).  Captive animal care met or exceeded the 
recommendations from the Sikes and Animal Care and Use Committee of the American 
Society of Mammalogists (2016). 
Microbiological Sampling 
Based on known exposure and carrier histories, we randomly selected captive 
individuals presumed to be carriers for our study.  Prior to capture, we permanently 
marked single polyurethane culture swabs (BD CultureSwabTM EZ System) with 8 
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equally spaced sections along the length of swab shaft and immediately replaced them 
into the swab tube.  We pre-labeled swab tubes with individual sheep identification, naris, 
and swab number (e.g., “L1–8” and R1–8”; Fig. 2).  To capture adults for sampling, we 
administered chemical immobilizing agents (BAM; 0.43 mg/kg butorphanol, 0.29 mg/kg 
azaperone, 0.17 mg/kg medetomidine, Wildlife Pharmaceuticals) intramuscularly using a 
CO2 powered dart projector (Pneu-dart, Williamsport, PA, USA).  
We ensured samples were collected in sequential order as presented on pre-
marked swab tubes.  We used one timekeeper, who operated a stopwatch and verbally 
called out time (seconds passed) when sampling, and one sample collector throughout our 
study.  We considered anterior and posterior swab samples to reflect marks 1–4 and 5–8, 
respectively (Fig. 2).  To initiate Movi detection samples, we simultaneously started a 
stopwatch and inserted a single polyurethane culture swab halfway (to the 4th mark) for 
anterior or fully (to the swab handle or 8th mark) for posterior samples into the specified 
naris.  As the stopwatch operator verbally indicated the time, the sample collector rotated 
the swab shaft while ensuring gentle contact with the mucosal tissue of the nasal wall and 
withdrawing the swab with circular motions to ensure each marked section of the swab 
was withdrawn at 1 second intervals (4 seconds total).   
We stored all samples at 4°C until the next day when we shipped all swabs 
overnight to Dr. Thomas Besser’s laboratory at Washington State University (Pullman, 
WA, USA).  We conducted laboratory assessments of sequential nasal swabs by 
extracting and amplifying Movi deoxyribonucleic acid (DNA) using realtime polymerase 
chain reaction (PCR) techniques (McAuliffe et al. 2003, Besser et al. 2008, Cassirer et al. 
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2017).  We considered a sample positive for Movi if fluorescence generation surpassed 
the threshold on or before the 36th of 40 PCR cycles. 
Statistical Analysis 
We used Bayesian logistic regression implemented through Nimble (NIMBLE 
Development Team 2018) in Program R (R Core Team 2018) to investigate the 
probability of detecting Movi from multiple nasal swab samples.  We investigated several 
different variables that we believed could affect detection rates.  The first covariate of 
interest was whether the sample was collected from the anterior or posterior of the nasal 
cavity based on swab insertion depth.  The second predictor variable was the order in 
which a swab was collected.  This was to assess if detection probability decreased with 
multiple sampling events (i.e., depletion of pathogen).  Thus, the linear model we used 
for this analysis was: 
logit(pi, j, k) = β0 + βloc xi, j, k + δj , 
where pi,j is the probability of detecting Movi using the j
th-ordered swab from the kth 
sampling (anterior vs. posterior) of the ith individual, β0 is the intercept term, βloc is the 
effect of sampling from the anterior of the nasal cavity, xi, j, k is an indicator of sampling 
from the anterior of the nasal cavity, and δj is the effect of being the j
th-ordered swab.  We 
modeled the observed detections as Binomial random variables: 
yi, j, k ~ Binomials (pi, j, k) . 
We specified diffuse Normal (0, 100) prior distributions for β0 and βloc.  We used 
an intrinsic conditionally auto-regressive prior for δj using a Normal distribution: 
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, Mτ)  , 
where δ-j was all of the swabs except the j
th-ordered swab, M was the number of 
neighboring swabs for the jth-ordered swab, 𝛬 was the set of all swabs that were 
neighbors of the jth-ordered swab (e.g., swabs number 1 and 3 are neighbors for swab 2), 
and τ was the precision term.  We specified a Gamma (1, 1) hyperprior for this precision.  
We enforced a sum-to-zero constraint for 𝛿 . 
We were also interested in comparing the impact of sampling both nares over 
sampling a single naris on the Movi detection probability, so we conducted the above 
analysis twice.  In the first analysis, for each individual, we treated each swabbing of a 
naris as independent sampling events using the model described above.  In the second 
analysis, we combined the detection results of sampling each naris into a single response 
for each individual using the model described above (i.e., if it was detected in at least one 
naris, we considered it detected).  We then reran the above model using the combined 
results.  Finally, we compared the difference in the detection probability estimates 
between sampling a single naris compared to both nares. 
RESULTS 
The median number of pooled detections per individual was 13 (range = 4–16) 
with an overall proportion of detections = 0.81.  Approximately half (45%; n = 5) of all 
individuals in our study reflected perfect detections (i.e., all samples were positive) in 
both nares (Fig. 3). The overall Movi mean detection probability for pooled bilateral 
upper respiratory samples was 0.18 higher (95% CI = 0.10–0.26) than unilateral samples.  
Movi detection probability attributed to sample order decreased as consecutive multiple 
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samples were taken, particularly for unilateral samples (unilateral mean detection 
probability range = 0.67–0.84), but differences were not statistically significant (Fig. 4; 
i.e., all 95% CI of the differences include zero) with the maximum difference, -0.11 (95% 
CI = -0.29–0.072) occurring between the last and first sample collected.  Overall mean 
detection probability was higher for anterior (0.80) as compared to posterior (0.73) nasal 
samples, but this is finding is not statistically significant (Fig. 4).   
Interestingly, approximately 20% (n = 2; Sheep IDs G57, Y33) of individuals 
consistently presented unilateral Movi infection (all 8 samples were positive detections) 
while the other naris seemed completely uninfected (all 8 samples were non-detections; 
Fig. 3).  We based our conclusion that these were unilateral infections rather than a 
failure to detect the pathogen’s presence because, given our estimated detection rates, 
there was only a 0.0000136 probability (95% CI = 7.60 e-07–5.99 e-05) the naris was 
infected and not detected given our sampling effort.  The mean Movi CT for the infected 
naris for G57 and Y33 was 28.29 (range = 26.90–28.99) and 27.80 (range = 26.49–
28.75), respectively, suggesting Movi colonization was relatively high in one naris but 
completely absent in the other.  An additional individual (Sheep ID Y56) was weakly 
positive (Movi CT = 35.60) in the first posterior sample, but indeterminate (Movi CTs = 
36.28 [swab Left1] and 37.34 [swab Left3]) or negative (Movi CT = 40 [swab Left2, 
Left4, Left6–8]) in all other samples for that naris (Fig. 3). 
We observed variable detection of Movi from some unilateral samples, but these 
observations primarily resulted from 2 individuals (Sheep IDs G20 and W7; Fig. 3).  
Sheep G20 presented consistently strong positive Movi PCR signals in all unilateral 
samples (Movi CT range = 18.15–20.39) in which Movi was detected, but Movi was not 
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detected in right unilateral samples 5, 6 and 8 (Movi CT = 40).  Comparatively, Sheep ID 
W7 presented weak positive Movi PCR signals in one naris (Movi CTs = 35. 75 [swab 
Left1], 35.60 [swab Left3], 34.76 [swab Left5]) but consistently stronger positive PCR 
signals (Movi CT range = 22.12–32.26) in the other naris (Fig. 3).   
One individual, Sheep ID Y60, was considered a subclinical chronic Movi carrier.  
Sheep Y60 was weakly positive (Left Movi CT = 35.28, 32.51; Right Movi CT = 35.76, 
35.20) in the first and second unilateral swabs and negative (Movi CT = 40) in all 
subsequent samples.  This may have reflected the only potential case where collection of 
multiple swabs affected the Movi PCR signal.  The probability that the pathogen was 
present after the first two samples were collected from each naris and then not detected in 
the subsequent 6 samples based on our estimated detection rates was extremely low (i.e., 
0.000376; 95%CI = 4.63 e-05–1.22 e-03), indicating potential impacts of multiple sample 
collections.  Additionally, the overall proportion of Movi detection for bilateral samples 
was 0.25 for this individual, which is the lowest in our study.  Samples 3–8 from this 
individual were also the only instance where we were not able to detect Movi in samples 
from at least one naris when using bilateral sampling (Fig. 3).   
DISCUSSION 
This is the first study to evaluate the impacts of protocols that rely on unilateral or 
bilateral sampling of the nasal cavities and collect serial samples on the detection 
probability of Movi in bighorn sheep.  Although unilateral nasal samples may produce a 
reliable result for a given individual, our results demonstrate the bilateral procedure 
increases the likelihood of pathogen detection (18% overall larger mean detection 
probability) when collecting 8 nasal swabs (Fig. 4).  Previous investigations report 
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bilateral respiratory samples are more likely to be positive than unilateral samples for 
human respiratory disease (Jonker et al. 2012), but to our knowledge, these studies have 
not previously occurred for free-ranging or domestic animal populations. 
An unexpected and previously undocumented finding of our study is the unilateral 
Movi colonization of nares in approximately 20% (n = 2) of the bighorn sheep 
investigated.  An additional animal had near unilateral colonization (1 unilateral sample 
was weakly positive, all others failed to detect Movi; Fig. 3).  Additionally, these 3 
animals had relatively strong positive PCR signals for all samples in the other naris 
indicating infection of that naris was relatively strong.  Although we did not include 
replicate sampling events for individuals, 1 of the 2 bighorn sheep (Sheep ID G57) was 
sampled on multiple days. During the initial sampling on 11 October 2016, the individual 
displayed unilateral (left naris) infection; during the second sampling on 17 November 
2016, we detected bilateral infection with some presumed false negatives in the left naris 
and all positives in the right naris; and during the final sampling on 23 January 2017, we 
noted unilateral (left naris) infection.  Although anecdotal, this suggests unilateral Movi 
colonization documented in our study is not stable.  Additional studies are warranted to 
describe the underlying process that leads to unilateral nasal colonization in infectious 
respiratory disease processes. 
Unilateral Movi colonization documented in our study may be driven by an 
underlying complex host-pathogen interaction and co-infections.  Fox et al. (2015) 
documented Movi detection probability in sinus lining tissue was strongly associated 
with the severity of sinus tumors and suspected sinus lining thickening could maintain 
pathogenic bacteria in the upper respiratory tract.  Further, bilateral and unilateral sinus 
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tumors were documented in 80% and 20%, respectively, of affected bighorn sheep in 
Colorado (Fox et al. 2015).  Purulent otitis media has been associated with Movi-induced 
pneumonia in bighorn sheep (Besser et al. 2008) and other Mycoplasma respiratory co-
infections in domestic hosts (Maeda et al. 2003, Lima et al. 2016).  Otitis media may also 
present unilateral infections in hosts but may be less frequent and less severe than 
bilateral middle ear infections, although overlap of clinical symptoms is common 
(Leibovitz et al. 2007, Ackermann et al. 2017). 
Wild and domestic animal disease studies have long recognized imperfect 
pathogen detection in most sampling and diagnostic tests (MacKenzie et al. 2002, Fablet 
et al. 2010, Walsh et al. 2016, DiRenzo et al. 2017); however, the effect of collecting 
multiple samples on detection probability and subsequent PCR signal decay had not been 
reported.  Although not statistically significant, our results indicate mean detection 
probability may have decreased as multiple samples were collected, particularly for 
unilateral swabs, but to our knowledge has not been reported elsewhere.  In 
approximately 90% of bilateral samples, Movi was detected in all samples for all known 
Movi carriers in our study.  However, 1 known subclinical Movi chronic carrier 
presented repeated non-detections in serial samples.  If investigators failed to record the 
order in which samples were sequentially collected and randomly selected bilateral 
samples 3–8, they would have yielded a false negative for this individual.   
The diagnostic procedures for Movi used in this study resulted in a high overall 
detection probability for 8 serial upper respiratory samples, which is within agreement 
with previous studies (Walsh et al. 2016, Butler et al. 2017).  It is imperative that disease 
ecologists have reliable diagnostic tools, particularly for the management of disease-
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limited wildlife populations such as bighorn sheep.  Laboratories that offer Movi 
diagnostics consistently provide reliable results, and median agreement of pooled Movi 
samples across all of these laboratories was 0.90 (Walsh et al. 2016).  Walsh et al. (2016) 
reported Movi CT values near the detection threshold (i.e., weak positive and/or negative 
samples) attributed to disagreements within and among laboratories.  Individual variation 
of weakly positive animals (i.e., Movi CT values near the detection threshold) may 
attribute to the lack of pathogen detection experienced in our study.  Our study 
anecdotally agrees with previous research efforts that conclude pathogen detection 
probability is related to host infection intensity (DiRenzo et al. 2017), but additional 
investigations are needed. 
MANAGEMENT IMPLICATIONS 
Infectious respiratory pathogen sampling methods should ensure repeatability and 
data quality.  Upper respiratory nasal swabs for laboratory diagnostics are generally non-
invasive and are the premier sample for Movi detection in bighorn sheep.  Wildlife 
managers should ensure sampling protocols explicitly require bilateral nasal swabs for 
Movi PCR analyses as this increases overall detection probability of this pathogen.  
Multiple bilateral nasal samples may be collected, and samplers should particularly 
ensure the anterior portion of nasal cavity (or front half of the swabs) is swabbed 
adequately.  When collecting more than 1 sample, however, managers should record the 
order at which samples were taken.  The first bilateral nasal sample should be the priority 
for laboratory assessments, and all other replicate samples could be banked for re-
analysis at a later date.   
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Figure 1. Wild bighorn sheep source herds selected for translocation to the South Dakota 











Figure 2. Permanently marked single polyurethane culture swabs with 8 equally spaced 
sections along the length of swab shaft.  The 4th permanent mark represents the start and 
stop of the anterior and posterior samples.  Swab numbers 1–4 were anterior samples and 














Figure 3. Mycoplasma ovipneumoniae detection history for 8 unilateral nasal swabs collected in left and right naris by 
individual bighorn sheep with known carrier histories used in our study.  We considered a sample positive for Movi if 
fluorescence generation surpassed the threshold on or before the 36th of 40 polymerase chain reaction (PCR) cycles. 
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Figure 4. Detection probability of Mycoplasma ovipneumoniae (Movi) in multiple (1–8) nasal swabs of captive bighorn sheep 
with known carrier histories.  Swabs were collected and analyzed based on order of sample collection (1–8), anatomical 
location (anterior (1–4) or posterior (5–8).  We report unilateral swabs separately and then pooled ordered unilateral swabs to 
establish bilateral ordered samples (e.g., Unilateral sample Left 1 and Right 1 were pooled for Bilateral 1 sample).  The mean 
Movi detection probability is presented as a circle and 95% credible intervals for multiple nasal samples are presented. 
 
